US20030181938A1 - Transluminal devices, systems and methods for enlarging interstitial penetration tracts - Google Patents
Transluminal devices, systems and methods for enlarging interstitial penetration tracts Download PDFInfo
- Publication number
- US20030181938A1 US20030181938A1 US10/346,556 US34655603A US2003181938A1 US 20030181938 A1 US20030181938 A1 US 20030181938A1 US 34655603 A US34655603 A US 34655603A US 2003181938 A1 US2003181938 A1 US 2003181938A1
- Authority
- US
- United States
- Prior art keywords
- debulker
- tissue
- tract
- counter
- lumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 C*(*)*C1(C)C#CCC=C1 Chemical compound C*(*)*C1(C)C#CCC=C1 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
- A61B17/32002—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes with continuously rotating, oscillating or reciprocating cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
- A61B18/245—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1482—Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
- A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22069—Immobilising; Stabilising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2255—Optical elements at the distal end of probe tips
- A61B2018/2266—Optical elements at the distal end of probe tips with a lens, e.g. ball tipped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B2018/2255—Optical elements at the distal end of probe tips
- A61B2018/2272—Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/03—Automatic limiting or abutting means, e.g. for safety
- A61B2090/033—Abutting means, stops, e.g. abutting on tissue or skin
- A61B2090/036—Abutting means, stops, e.g. abutting on tissue or skin abutting on tissue or skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
- A61B2090/065—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure
Definitions
- the present invention relates generally to medical devices and methods, and more specifically to transluminal devices, systems and methods which are useable to enlarge interstitial tracts (e.g., man made puncture tracts or small passageways) which extend between two (2) anatomical conduits (e.g., blood vessels) or otherwise through tissue(s) within a mammalian body.
- interstitial tracts e.g., man made puncture tracts or small passageways
- anatomical conduits e.g., blood vessels
- passageway-forming catheters are advanced into anatomical conduits (e.g., blood vessels) and are used to create one or more interstitial passageways which extend outwardly, from the conduit in which the catheter is positioned, to another conduit or anatomical structure.
- Some of these procedures may be used to form flow-through passageways between the anatomical conduit (e.g., blood vessel) in which the passageway-forming catheter is positioned, and another anatomical conduit (e.g., another blood vessel) or a different location on the same anatomical conduit (e.g., a downstream site on the same blood vessel).
- these procedures may be used to form access passageways between the anatomical conduit (e.g., blood vessel, urethra, fallopian tube, etc..) and another anatomical structure (e.g., a tumor, organ, muscle, nerve, etc.).
- anatomical conduit e.g., blood vessel, urethra, fallopian tube, etc..
- another anatomical structure e.g., a tumor, organ, muscle, nerve, etc.
- the interstitial passageway(s) are initially formed by advancing a tissue-penetrating element (e.g., a small diameter needle or a flow of tissue-penetrating energy) from the passageway-forming catheter, through the wall of the anatomical conduit in which the catheter is positioned, and into the target location.
- a tissue-penetrating element e.g., a small diameter needle or a flow of tissue-penetrating energy
- the interstitial passageway which is formed by the initial passage of the tissue-penetration element from the passageway-forming catheter is of relatively small diameter—and must subsequently be enlarged (e.g., debulked, dilated, expanded, stretched) to accommodate the desired flow of biological fluid (e.g., blood) or passage of other substances/ devices therethrough.
- such enlargement of the initially formed interstitial passageway may be particularly important when the procedure is being performed to by-pass an obstruction within a coronary artery.
- a primary interstitial passageway is formed between an obstructed coronary artery and an adjacent coronary vein, such that blood will flow from the obstructed artery into the adjacent coronary vein.
- the arterial blood which enters the adjacent coronary vein through the primary interstitial passageway is allowed to retroperfuse the ischemic myocardium by retrograde flow through the coronary vein.
- one or more secondary interstitial passageways are formed between the coronary vein into which the arterial blood has flowed and the obstructed artery (or some other coronary artery) to allow arterial blood which has entered the coronary vein to reenter the obstructed artery (or some other coronary artery), after having bypassed the arterial obstruction.
- the primary and/or secondary interstitial passageway(s) remain patent and sufficiently large in diameter to support the continued flow of arterial blood to the myocardium.
- the task of enlarging the small diameter interstitial passageway(s) (e.g., puncture tracts) formed by the initial passage of the tissue-penetrating element presents numerous technical challenges.
- catheter-based devices which may be used to enlarge or remove obstructive matter from the lumen of a blood vessel or other anatomical conduit (e.g., a blood vessel).
- these devices include; atherectomy catheters, embolectomy catheters, balloon angioplasty catheters, laser ablation catheters, etc.
- these prior art lumen-enlarging/lumen-clearing devices have typically not been intended for use in small diameter puncture tracts which diverge at an angle from the conduit lumen in which the catheter is located, as is typically the case in applicant's above-summarized interventional procedures.
- interstitial penetration tracts e.g., man-made punctures or small passageways
- anatomical conduits e.g., blood vessels
- the present invention provides devices which are useable in combination with each other (i.e., as a system) to enlarge an interstitial tract (e.g., a small diameter penetration tract through tissue) which extends from a blood vessel or other anatomical conduit of the body.
- the devices and systems of the present invention generally fall into three (3) major classifications—1) debulking-type tract enlargement systems, 2) dilating-type tract-enlargement systems, and 3) slicing-type tract enlargement systems.
- one debulking-type tract enlargement system (referred to herein as an “advancable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough; b) a counter-traction member which is advanceable, i.) through the lumen of the tubular sheath and ii.) at least partially through the interstitial tract, such that the countertraction member engages or becomes positioned in relation to tissue which lies adjacent the interstitial tract to thereafter exert proximally-directed force upon such tissue; and, c) a debulker (e.g., a tissue removing apparatus or flow of energy) which is advanceable out of the lumen of the sheath in a distal direction (i.e., substantially opposite the proximally-directed force being exerted by the
- another debulking-type tract enlargement system (referred to herein as a “retractable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a pull-back debulker (e.g., a tissue-removing apparatus or flow of energy) which is i.) initially advanceable out of the lumen of the sheath in a distal direction so as to pass through the penetration tract which is to be enlarged, and ii.) thereafter retractable in the proximal direction so as to remove tissue which lies adjacent the interstitial tract, thereby enlarging the interstitial tract.
- a pull-back debulker e.g., a tissue-removing apparatus or flow of energy
- a dilating-type tract enlargement system (referred to herein as a “dilating” system) which generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a dilator (e.g., an elongate member) having at least one tissue-dilating member (e.g., a tapered, frusto-conical member, balloon or radially deployable member(s)) formed thereon, such dilator being advanceable into the penetration tract which is to be enlarged, and is subsequently useable to dilate such penetration tract, thereby resulting in the desired enlargement thereof.
- tissue-dilating member e.g., a tapered, frusto-conical member, balloon or radially deployable member(s)
- a positioning surface may be formed on the dilator to abut against tissue which lies adjacent the passageway in a manner which will enable the operator to determine that the dilator has been advanced to its desired position and is properly located to allow the dilate the interstitial tract as desired.
- tissue-slicing system which generally comprises a) an elongate shaft which is advanceable through the interstitial tract, and b) at least one tissue slicing member which extends or is extendable from the shaft to incise or cut tissue which lies adjacent the interstitial tract as the shaft is advanced and/or retracted through the tract.
- the tissue slicing member(s) may be initially disposed in a radially compact configuration which is flush with, or only slightly protrusive beyond, the outer surface of the shaft, thereby allowing the shaft to be advanced through the interstitial tract without cutting or disrupting the surrounding tissue. Thereafter, the tissue slicing member(s) is/are shifted to a radially expanded configuration wherein such tissue-slicing member(s) extend or protrude laterally from the shaft so as to slice, incise or cut at least some of the tissue which surrounds the tract.
- the tissue-slicing member(s) need not be concentric about the shaft, but rather may be of substantially flat configuration so as to create a defined incision or cut in the tissue.
- tissue-slicing member(s) may be configured so as not to completely sever and remove tissue in the manner of the above-sumarized debulking-type embodiment, but rather may simply form a slit or incision adjacent the tract such that the surrounding tissue will continuously or intermittantly separate to allow flow of fluid (e.g., blood) therethrough.
- fluid e.g., blood
- a two-catheter type tract enlarging system (referred to herein as a “two-catheter” system) which is specifically useable to enlarge an interstitial tract or passageway which has been formed between two adjacent anatomical conduits (e.g., blood vessels).
- Such two-catheter system generally comprises a) a first catheter having a tract-enlarging apparatus (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) which is advancable from an opening at or near the distal end of that catheter, and b) a second catheter which has an anvil member (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter.
- the first catheter is positioned in one of the anatomical conduits
- the second catheter is positioned in the other anatomical conduit, with its anvil member located next to the interstitial tract or passageway which is to be enlarged.
- the tract enlarging apparatus is advanced through the tract or passageway until it registers with (e.g., abutts against or is received with) the anvil member of the second catheter.
- the anvil member serves to provide counterforce against the tissue adjacent the initially formed tract or passageway so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.
- either the debulking-type, dilating type, tissue-slicing type or two catheter type tract enlargement systems of the present invention may incorporate a guidewire lumen which extends longitudinally through the i.) tract enlarging member (e.g., debulker, dilator or tissue slicing member) to permit the tract enlarging member to be advanced over a small guidewire which has previously been passed through the penetration tract which is to be enlarged.
- the provision of such guidewire lumen may permit the system to be used to dilate penetration tracts which are of extremely small diameter, or which have become substantially closed off due to constriction of the surrounding tissue, provided that a guidewire was previously inserted through such penetration tract.
- energy such as radio-frequency energy or electrical resistance heat may be applied to the tract enlarging member (e.g., debulker, dilator, or tissue slicing member) to enhance the tract-enlarging efficiency thereof.
- the tract enlarging member e.g., debulker, dilator, or tissue slicing member
- FIG. 1 is a perspective view of a debulking-type tract enlarging system of the present invention.
- FIG. 2 is a schematic perspective view of a human body having the tract enlarging system of FIG. 1 operatively inserted into the coronary vasculature.
- FIG. 2 a is an enlarged, cut-away view of segment 2 a - 2 a of FIG. 2.
- FIG. 3 is an enlarged sectional view through line 3 - 3 of FIG. 2 a.
- FIGS. 3 a - 3 d are step-wise showings of a presently preferred method for using the tract enlarging system of FIG. 1 to debulk and enlarge an interstitial penetration tract which has been created between a coronary artery and an adjacent coronary vein.
- FIG. 4 is an enlarged, side elevational view of the distal portion of the tract enlarging system of FIG. 1.
- FIG. 4 a is a cross sectional view through line 4 a - 4 a of FIG. 4.
- FIG. 4 b is a cross sectional view through line 4 b - 4 b of FIG. 4.
- FIG. 4 c is a cross sectional view through line 4 c - 4 c of FIG. 4.
- FIG. 5 a is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
- FIG. 5 b is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
- FIG. 6 is a is a longitudinal sectional view of the distal portion of the subselective sheath component of the system of FIG. 1.
- FIG. 7 is a is a longitudinal sectional view of the distal portion of the tissue cutter component of the system of FIG. 1.
- FIG. 7 a is an exploded, longitudinal sectional view of the distal potion of the tissue cutter of FIG. 7.
- FIG. 8 is a side elevational view of the counter-traction member component of the system of FIG. 1.
- FIG. 8 a is an exploded, longitudinal sectional view of the distal potion of the counter-traction member of FIG. 8
- FIG. 9 a shows a first alternative counter-traction member having a tissueengaging member formed of radially expandable members, wherein the radially expandable members are in their collapsed configuration.
- FIG. 9 b shows the first alternative counter-traction member of FIG. 9 a , with its radially expandable members in a partially expanded configuration.
- FIG. 9 c shows the first alternative counter-traction member of FIG. 9 a , with its radially expandable members in their fully expanded configuration.
- FIG. 10 a is a side elevational view of a debulking-type tract enlarging system which is equipped with a first type of an energy emitting debulker (e.g., a radio-frequency system).
- a first type of an energy emitting debulker e.g., a radio-frequency system
- FIG. 10 b is an enlarged perspective view in the distal end of the energy-emitting debulker of FIG. 10.
- FIG. 10 c is a cross sectional view through line 10 c - 10 c of FIG. 10 a.
- FIG. 10 d is a side elevational view of the distal portion of an another alternative debulking-type system which comprises an energy-emitting debulker in conjunction with an energy emitting counter-traction member, and wherein the energy emitting counter-traction member is in a retracted position.
- FIG. 10 e shows the system of FIG. 10 c with its energy-emitting countertraction member in its extended position.
- FIG. 10 f is a cross sectional view through line 10 e - 10 e of FIG. 10 d.
- FIG. 10 g is a side elevational view of the distal portion of another energy-emitting debulker which incorporates an annular array of laser-transmitting optical fibers.
- FIG. 10 g ′ is a distal end view of the debulker of FIG. 10 g.
- FIG. 10 h is a side elevational view of the distal portion of another energy-emitting debulker which incorporates a central laser-transmitting optical fiber (or fiber bundle) in combination with a prism which disseminates the laser light in an annular array to effect the desired severing or vaporization of tissue.
- FIG. 11 a shows a debulking-type tract enlarging system having an advanceable debulker and a second alternative counter-traction member having a tissue-engaging member formed of an inflatable balloon, wherein the inflatable balloon is in its non-inflated, collapsed configuration.
- FIG. 11 b is a cross sectional view through line 11 b - 11 b of FIG. 11 a.
- FIG. 11 c shows the second alternative counter-traction member of FIG. 11 a , with its balloon in a fully inflated, expanded configuration.
- FIG. 11 d shows the second alternative countertraction member of FIG. 11 a , with its balloon in its fully inflated, expanded configuration and the shaft fully retracted into the lumen of the debulker.
- FIG. 11 e shows a debulking-type tract enlarging system having an advanceable debulker and a third alternative counter-traction member which comprises a plurality of outwardly splayable tissue-engaging members, wherein the tissue-engaging members are in there radially collapsed configuration and the counter-traction member is only slightly advanced out of the debulker.
- FIG. 11 f shows the system of FIG. 11 e wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member is being further advanced out of the debulker.
- FIG. 11 g shows the system of FIG. 11 f wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member is fully advanced out of the debulker.
- FIG. 11 h shows the system of FIG. 119 wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member has been fully retracted such that the distal end of the debulker engages the interior of the expanded tissue-engaging members.
- FIG. 12 a is a side elevational view of the distal portion of a retractable debulking-type tract enlarging system of the present invention, wherein the retractable debulker is disposed in a distally extended position.
- FIG. 12 b is a view of the system of FIG. 12A, wherein the debulker is disposed in a partially retracted position.
- FIG. 13 is a side elevational view of a dilation-type tract enlarging system of the present invention, disposed with its dilator (i.e. balloon) in a stowed (i.e., deflated) position.
- dilator i.e. balloon
- stowed i.e., deflated
- FIG. 13 a is view of the system of FIG. 13, disposed with its dilator (i.e., balloon) in an operative (i.e., inflated) position.
- dilator i.e., balloon
- operative i.e., inflated
- FIG. 13 b is a cross sectional view through line 13 b - 13 b of FIG. 13.
- FIG. 13 c is a cross sectional view through line 1 3 c - 1 3 c of FIG. 13.
- FIG. 14 is a graphic illustration of a continuous emission of radiofrequency energy in accordance with the present invention.
- FIG. 15 is a graphic illustration of intermittant or pulsed emission of radiofrequency energy in accordance with the present invention.
- FIG. 16 is a longitudinal sectional view of the distal portion of a debulker of the present invention which incorporates an apparatus for controlling the pressure appplied by the debulker and/or for signifying when the debulking procedure is complete.
- FIG. 17 is a side elevational view of the distal portion of a tissue-cutting type of tract enlarging system of the present invention.
- FIG. 18 a is a side elevational view of an alternative tissue-cutting tip for the system of FIG. 17.
- FIG. 18 b is a top plan view of the alternative tissue-cutting tip of FIG. 18 a.
- FIG. 18 c is a distal end view of the alternative tissue cutting tip of FIG. 18 a.
- FIG. 19 is a schematic showing of two adjacent blood vessels having a penetration tract formed therebetween, and a two-catheter tract enlarging system of the present invention operatively disposed therein to enlarge the penetration tract.
- debulking-type tract enlargeing systems 10 and 10 a include debulking-type tract enlargeing systems 10 and 10 a , dilating-type tract enlargement systems 10 b , and tissue-slicing-type tract enlarging systems 10 c.
- the debulking-type systems 10 , 10 a serve to remove (e.g., cut, sever, ablate, vaporize, etc.) tissue which surrounds or lies adjacent to the initially formed interstitial tract thereby enlarging the tract.
- the description set forth in the following paragraphs includes a distally advanceable debulking-type system 10 as well as a proximally retractable debulking-type system 10 a.
- FIGS. 1 - 9 show a preferred, distally-advanceable debulking-type tract enlargeing system 10 which is useable to enlarge a penetration tract.
- this distally advanceable debulking system 10 generally comprises a) a subselective sheath 12 , b) a distally-advanceable debulker 14 which is passable out of the subselective sheath, in a distal direction DD, and a counter-traction member 16 which is advanceable through the penetration tract ahead of the debulker 14 , and engageable with tissue adjacent the tract to exert a counter-force (i.e.
- the counter-traction member 16 may simily be positioned adjacenyt the tissue such that it does not actually exert force against the tissue until the debulker 14 is advanced into contact with the tissue, at which time the tissue will then be compressed between the debulker and the counter-traction member 16 as the debulking procedure is performed.
- the subselective sheath 12 of the embodiment shown in the drawings comprises a flexible tube which is sized to be advanceable into the anatomical conduit from which the interstitial penetration tract extends.
- the preferred subselective sheath 12 comprises inner wall 30 preferably formed of formed of polytetrafluoroethylene (PTFE), an outer wall 32 preferably formed of polyether block amide polymer (e.g., PebaxTM), and a braid 34 captured between inner 30 and outer 32 walls, such braid 34 terminating distally at a location which is approximately 2-10 mm from the distal end of the sheath 12 .
- PTFE polytetrafluoroethylene
- an outer wall 32 preferably formed of polyether block amide polymer (e.g., PebaxTM)
- a braid 34 captured between inner 30 and outer 32 walls, such braid 34 terminating distally at a location which is approximately 2-10 mm from the distal end of the sheath 12 .
- non-braided distal portion 36 of approximately 2-10 mm and a braided proximal portion 38 .
- the presence of the braid 34 within the proximal portion 38 of the sheath 12 enhances its strength and resistance to crimping or kinking, while the non-braided distal portion 36 of the sheath 12 remains soft and pliable to avoid injury or damage to the walls of blood vessels or other tissues, as the sheath 12 is advanced.
- the sheath 12 will preferably have an outer diameter of 0.050-0.150 inch and an inner lumen diameter of 0.040-0.140 inch.
- the subselective sheath 12 may have lumen which curves laterally and exits through an outlet port formed in the sidewall of the sheath 12 .
- Such side outlet sheath (not shown) may be advanced to a position where the side outlet aperture is in direct alignment with the penetration tract PT which is to be enlarged. Thereafter, the debulker 14 may be advanced out of the side outlet aperture and directly through tissue which surrounds the penetration tract PT.
- the debulker 14 of the embodiment shown in the drawings comprises a rotating tissue cutter which, when advanced in the distal direction and concurrently rotated, will sever and remove a cylindrical mass of tissue which surrounds the penetration tract.
- this preferred debulker 14 comprises a flexible tube 40 which has a lumen 44 extending longitudinally therethrough, and an annular cutting member 42 mounted on the distal end thereof.
- the annular cutting member 42 has a sharpened leading edge 46 and a hollow bore 48 which extends therethrough.
- the cutting member 42 is mounted securely on the distal end of the tube, preferably such that the bore 46 of the annular cutting member 42 is in direct axial alignment with the lumen 44 of the tube 40 , and the outer surface of the cutting member 42 is flush with the outer surface of the tube 40 .
- the tube 40 is preferably formed of a flexible plastic such as polyether block amide polymer (e.g., PebaxTM) and the cutter member 42 is preferably formed of a rigid material such as stainless steel. In embodiments intended for use in coronary blood vessels, this debulker 14 will preferably have an outer diameter of 0.05-0.13 inches and an inner (lumen) diameter of 0.04-0.12 inches.
- a plurality of bearing members 50 may be mounted at spaced-apart locations within the lumen 44 of the debulker 14 to facilitate rotation of the debulker 41 about a central shaft (e.g., the shaft 60 of the countertraction member 16 ).
- a drive motor/handpeice 22 may be mounted on the proximal end of the debulker 14 , as shown in FIGS. 1 and 7. This drive motor/handpeice 22 , when actuated, will rotationally drive the debulker 14 , at a suitable rate of rotation to facilitate the desired severing of tissue. In applications where the debulker 14 is being used to sever soft tissue, it is preferable that the motor/handpeice 22 be capable of driving the debulker 14 at 60-300 revolutions per minute.
- One example of a commercially available drive motor/handpeice 22 which may be used is the MDV Motor Drive Unit manufactured by DVI , Inc.
- the counter-traction member 16 of the embodiment shown in the drawings serves to pass through the interstitial tract to be enlarged, ahead of the debulker, and prevents unwanted protrusion or “tenting” of the tissue into the adjacent anatomical conduit, thereby enhancing the tissue cutting efficience of the debulker.
- the preferred counter-traction member 16 comprises an elongate, pliable shaft 60 having a dilator/tissue-engaging member 62 mounted on the distal end thereof, and a guidewire lumen 67 .
- the tract dilator/tissue engaging member 62 comprises a frustoconical body 68 and a cutting-engagement plate 64 formed on the proximal end thereof.
- the proximal surface 66 of the cutting-engagement plate 64 is disposed in a plane P which is substantially perpendicular to the longitudinal axis LA of the shaft 60 .
- the frustoconical portion is preferably formed of soft plastic such as polyether block amide polymer (e.g., PebaxTM) and the cutting/engagement plate 64 is preferably formed of hard material such as polycarbonate or stainless steel. As shown in the exploded view of FIG.
- a cavity 73 may be formed in the proximal end of the dilator/engagement plate 62 , including a shaft receiving portion 74 and an annular groove 70 .
- the distal portion 65 of the cutter/engagement plate 64 is inserted into cavity 73 such that an annular shoulder 72 formed about the proximal portion 65 will frictionally engage a corresponding annular groove 70 formed about the interior of the cavity 73 , thereby holding the cutting/engagement plate 64 in fixed position on the distal end of the dilator/engagement member 62 .
- the distal end of the shaft 60 is then inserted through the bore 67 of the cutting/engagement plate 64 until it bottoms out in the shaft receiving portion 74 of the cavity 73 .
- An adhesive or thermal compression bonding may be used to securely hold the shaft in contact with the dilator/engagement member 62 .
- the proximal portion 65 of the cutting/engagement plate 64 may act as a ferrule, exerting radial inward pressure against the shaft to frictionally hold the shaft in its inserted position within the cavity.
- the counter-traction member 16 also acts to protect the adjacent vessel or luminal anatomical structure from iatrogenic trauma (e.g., perforation, laceration) as the debulker is advanced.
- tissue-engaging members may be utilized in addition to, or as an alternative to the particular counter-traction member 16 shown in FIGS. 1 - 8 .
- Some examples of alternative types of countertraction members 16 a , 16 b , 16 c are shown in FIGS. 9 a - 9 c and 11 a - 11 h.
- one alternative counter-traction member 16 a comprises a telescoping shaft 80 formed of a distal shaft portion 80 ′ and a proximal shaft portion 80 ′′, having a plurality of radially expandable members 82 disposed about the shaft 80 , as shown.
- a guidewire lumen (not shown) extends longitudinally through the shaft 80 .
- Each radially expandable member 82 has a distal end which is affixed to the distal shaft portion 80 ′ and a proximal end which is affixed to the proximal shaft portion 80 ′′. As shown in FIG.
- another alternative counter-traction member 16 b comprises an elongate shaft 90 which has a guidewire lumen 92 and a balloon inflation/deflation lumen 94 extending therethrough, and a balloon 96 mounted thereon.
- the shaft 90 With the balloon in its deflated state as shown in FIG. 1 Oa, the shaft 90 is advanceable over a gudewire and through the penetration tract PT which is to be enlarged. After the balloon 96 has emerged out of the opposite end of the penetration tract PT, inflation fluid is injected through the inflation/deflation lumen 94 to inflate the balloon 96 as shown in FIG. 10 c .
- the inflated balloon 96 will the abut against and engage the tissue which surrounds the penetration tract PT, and will exert proximally directed force on such tissue while the debulker 14 is advanced through the tissue.
- the shaft 90 will be fully retracted into the lumen 44 of the debulker 14 and the cutting surface 46 of the annular cutting member 42 will abut against a reinforced region 98 of the balloon.
- Such reinforced region 98 is sufficiently resistant to cutting or puncture to prevent the annular cutting member 42 from bursting or penetrating through the wall of the balloon 96 .
- FIG. 11 e - 11 h there is shown yet another counter-traction member 16 c which comprises an elongate shaft 150 having a plurality of resilient or spring loaded, outwardly splayable members 160 which are attached at their distal ends to the shaft 150 .
- the proximal ends of the splayable members 160 are biased to a radially expanded configuration as shown in figures 11 f - 11 h , but are initially compressible to a radially compact configuration wherein they may be receieved within the lumen 44 of the debulker, as shown in FIG. 11 e .
- the shaft 150 is advanced in the distal direction to drive the splayable members 160 through the interstitial tract.
- proximal ends of the splayable members emerge from the distal end of the interstitial tract, they will spring outwardly to their radially expanded configuration and will engage the tissue adjacent the distal end of the tract.
- proximally directed pressure may be applied to the shaft as the debulker 40 is advanced in the distal direction.
- FIGS. 3 a - 3 d show a specific coronary revascularization procedure wherein an interstitial passageway is to be formed between a coronary vein CV and an adjacent coronary artery CA, to permit arterial blood to flow into the coronary vein CV.
- a small guidewire GW is passed through such penetration tract PT.
- the guidewire GW is passed, proximal end first, into the distal end of the guidewire lumen 67 which extends through the counter-traction member 16 .
- the system 10 is advanced over the guidewire GW until the distal end of the subselective sheath 12 becomes positioned within the coronary vein CV at a location approximately 0.10 inch (i.e., 2-3 mm) from the penetration tract PT. Thereafter, as shown in FIG. 3, the counter-traction member is further advanced such that the dilator/engagement member 62 will pass through the penetration tract PT and into the coronary artery CA.
- the tissue surrounding the penetration tract PT will elastically retract about the distal portion of the shaft and the proximal surface 66 of the cutting/engagement plate 64 will abut against the coronary artery wall immediately adjacent the opening of the penetration tract PT into the coronary artery CA.
- proximally directed pressure is applied to the counter-traction member 16 while concurrently advancing the debulker 14 in the distal direction, as shown in FIG. 3 a .
- the drive motor/handpeice 22 is actuated so as to rotate the debulker at approximately 60-300 RPM. As shown in FIG.
- this causes the sharpened leading edge 46 of the cutting member 42 to cut a cylindrical bolus of tissue as the rotating debulker 14 continues to advance.
- the application of proximally directed pressure on the counter-traction member 16 concurrently with the distally directed advancement of the debulker 14 prevents the surrounding tissue from “tenting” and enhances the cutting efficiency of the debulker 14 .
- the severed bolus of tissue will be prevented from escaping into the coronary artery CA, and will be forced into the lumen of the debulker 14 whereby it may be extricated and removed from the body along with the debulker 14 , as illustrated in FIG. 3 c . This results in the formation of an enlarged bloodflow passageway EBP, as desired.
- one or more embolic blockers B or other flow-blocking means may be utilized to prevent arterial blood which enters the coronary vein CV through the enlarged bloodflow passageway EBP from flowing in the venous return direction, and to cause such arterial blood to flow through the coronary vein CV in the retrograde direction, thereby bypassing the obstruction OB located in the adjacent coronary artery CA.
- FIGS. 12 a - 12 b show an example of a retractable debulking-type tract enlargement system 10 a , of the present invention.
- This system 10 a comprises a proximal counter-force member 112 in combination with a retractable debulker 14 a , as shown in FIGS. 12 a and 12 b.
- the proximal counter-force member 112 comprises a tube having a lumen (not shown) which extends longitudinally therethrough and an annular cutting/engagement plate 100 formed on the distal end thereof.
- the annular cutting/engagement plate 100 serves to engage a pull-back tissue cutter formed on the proximal end of the retractable debulker 14 a .
- a plurality of bearings 50 of the type described hereabove may be coaxially disposed at spaced apart locations within the lumen of the proximal counter-force member 112 .
- the retractable debulker 14 a of this embodiment comprises a shaft 102 having a flexible frusto-conical dilator 104 formed thereon, and an annular cutter member 106 mounted on the proximal end of the dilator 104 , as shown.
- the frusto-conical dilator 104 may be constructed and configured the same as the frustoconical body 68 described hereabove.
- the annular cutting memebr 106 may be constructed and configured the same as the annular cutting member 42 of the first embodiment described hereabove. This annular cutting member 106 has a sharpened proximal edge 108 which will sever tissue when retracted therethrough.
- a guidewire lumen(not shown) extends longitudinally through the shaft 102 and through the frusto-conical dilator.
- the retractable debulker 1 4 a may be rotatably driven by a drive motor/handpeice 22 as described hereabove.
- this retractable debulking type system 1 Oa Prior to operation, this retractable debulking type system 1 Oa is assembled such that shaft 100 the retractable debulker 14 a is slidably and (and in some cases rotatably) disposed within the lumen of the proximal counter-force member 112 .
- the shaft 102 will extend through any bearings 50 disposed within the lumen of the counter-force member 112 .
- the shaft 102 may initially be retracted such that the proximal sharpened edge 108 of the annular cutter 106 is in abutment with the annular cutting plate 100 .
- the counter-force member 1 12 and retractable debulker 14 a are positioned within the lumen 31 of a subselective sheath 12 as described hereabove.
- This system 1 Oa may then be utilized to enlarge a small penetration tract PT which has been formed through the sidewall of and extending outwardly from an anatomical conduit of the body, and through which a guidewire has been inserted.
- the guidewire GW which extends through the penetration tract is inserted into the distal end of the guidewire lumen (not shown) of the retractable debulker 14 a .
- the subselective sheath 12 having the counterforce member 112 and retractable debulker positioned therewith, is maneuvered into the anatomical conduit from which the penetration tract extends. Thereafter, the shaft 102 of the retractable debulker 14 a is advanced such that the dilator 104 is forced through the penetration tract. After the sharpened proximal edge 108 of the retractable debulker 14 a has emerged out of the opposite end of the penetration tract, the tissue which surrounds the penetration tract will elastically constrict about the shaft.
- the counter-force member 112 is then advanced until the distal annular cutting plate 100 is in abutment with the wall of the portion of the wail of the anatomical conduit which surrounds the proximal end of the penetration tract.
- distally directed counter-force is applied to the counter-force member 112 while the retractable debulker 14 a is retracted in the proximal direction.
- the retractable debulker 14 a may be rotated concurrently with its retraction.
- the sharpened proximal edge 108 of the annular cutting member 106 will sever a generally cylindrical bolus of tissue which surrounds the puncture tract, thereby accomplishing the desired enlargement of the initially formed penetration tract.
- the severed bolus of tissue will be drawn into, and captured within, the lumen (not shown) of the counter-force member 112 as the sharpened proximal edge 108 of the annular cutting member 106 is retracted into contact with the annular cutting plate 100 .
- the counter-force member 112 (having the severed bolus of tissue contained therewithin) and the retractable debulker 14 a , may be removed from the body along with the subselective sheath 12 .
- the particular geometry of the cutter member 42 can assist in creation of the optimal passage, such as the enlarged bloodflow passageway EBP of the foregoing example.
- the annular cutting member 42 need not be of circular cross-sectional configuration as shown in FIG. 7 a , but rather may be of oblong or oval configuration. Such oblong or oval shape of the annular cutting member 42 , when advanced through the puncture tract without rotation thereof, will form a channel of oval or oblong cross-sectional shape.
- the annular cuttiong member 42 may be of tapered outer diameter, such that its distal cutting edge is of a first diameter d x and its proximal end is of a second diameter d y . Such tapering of the annular cutting member 42 causes the tissue which is cut by the cutting edge 46 to expand as the debulker 14 is advanced, thereby resulting in a more predictable diameter of the resultant channel.
- FIGS. 10 a - 10 c show one energy-emitting debulking-type system which incorporates a bipolar, energy-emitting debulker 14 ′.
- FIGS. 10 d - 10 f show another energy-emitting, debulking-type system one electrode is located on an energy-emitting debulker 14 ′′′ and another electrode is located on an energy-emitting counter-traction member 16 ′′.
- the bipolar, radiofrequency debulker 14 ′ comprises an elongate tubular member 40 ′ having a hollow lumen 44 ′ extending longitudinally therethrough.
- First and second energy-transmitting members 204 a , 204 b extend longitudinally through the tubular member 44 ′, as shown in the cross sectional view of FIG. 10 c .
- a debulking electrode tip 205 is mounted on the distal end of the tubular member.
- Such electrode tip 205 incorporates a first radiofrequency-emitting electrode 206 and a second radiofrequency-emitting electrode 208 , as shown in FIG. 10 b .
- the first energy transmitting member 204 a is connected to the first electrode 206 and the second energy transmitting member 204 b is connected to the second electrode 208 .
- An annular insulator body 210 is disposed between the electrodes 204 a , 204 b .
- a bipolar radiofrequency generator 200 is connected by way of a wire 202 to the first and second energy transmitting members 204 a , 204 b such that a circuit is completed between the generator 200 and the respective first and second electrodes 206 , 208 .
- the generator may be energized to cause radiofrequency current to pass between the annular distal surfaces of the first and second electrodes 206 , 208 , thereby effecting bipolar cutting or ablation of the tissue which surrounds the interstitial tract.
- the first electrode 206 a is mounted on the distal end of the debulker 14 ′′ and the second electrode 208 a is mounted on the proximal end of the countertraction member 16 ′′, as shown.
- the first energy transmitting member 204 a extends through the tubular member 40 ′′ of the debulker 14 ′′ while the second energy transmitting member 204 b extends through the shaft 60 ′′ of the countertraction member 16 ′′.
- the first energy transmitting member 204 a is connected to the first electrode 206 a of the second energy transmitting member 204 b is connected to the second electrode 208 a .
- FIGS. 10 a - 10 f similar monopolar embodiments may also be devised through the alternate use of a separate antenna or plate electrode wich attaches to the patients body to complete the circuit.
- Such monopolar embodiments may utilize only a single electrode 204 or 206 to accomplish the desired cutting or ablation of tissue.
- the radiofrequency energy may be applied continuously at 100 KHz-2 MHz, and preferably at about 500 KHx (i.e., 70 watts) until the cutting operation is complete.
- such radiofrequency energy may be delivered intermittently, in pulsed fashion, to avoid necrosis or damage to the adjacent tissue.
- the duty cycle of the pulsed energy will optomized to provide efficient tissue cutting while avoiding damage to surrounding tissue.
- FIGS. 10 g - 10 i show variants of a laser emitting debulker 14 b , wherein laser energy is used to cut or vaporize the tissue.
- the embodiment shown in FIGS. 10 g and 10 g ′ comprises an elongate flexible member having a guidewire lumen 73 extending longitudinally therethrough, and a plurality of longitudinally extending, parallel optical fiber bundles 71 disposed in a generally circular array about the outer perimeter of the member, such optical fiber bundles 71 terminating distally in lenses or other laser emitting surfaces 77 such that a generally conical or annular pattern of laser light is projected from the distal end of the debulker 14 b.
- FIGS. 10 h and 10 h ′ show an alternative laser emitting debulker 14 b ′ wherein a central laser-transmitting optical fiber bundle 75 extends longitudnially through a portion of the debulker 14 b ′ and terminates proximal to a generally conical cavity 76 formed in the distal end of the debulker 14 b ′.
- a stationary prism 77 having a plurality of light guide grooves 78 formed thereabout, is mounted on the distal end of the fiber bundle 75 such that a generally conical pattern of laser light is projected from the prism, through the conical cavity 76 and out of the distal end of the debulker 14 b ′.
- An optional suction lumen 79 may be provided in any of these laser embodiments, to enhance their efficiency (as described more fully herebelow) and/ or to aspirate away any residue or tissue particle which become severed during the procedure.
- FIGS. 10 i and 10 i ′ show another alternative laser emitting debulker 14 b ′′ wherein the central laser-transmitting optical fiber bundle 75 ′ is rotatable, terminates proximal to a generally conical cavity 76 formed in the distal end of the debulker 14 b ′.
- negative pressure may be applied through the lumen of the debulker 14 , 14 a to a) tension the tissue being cut so as to improve the cutting efficiency and/or predictability of the cut and/or b) draw the severed tissue into the lumen of the debulker 14 , 14 a so as to capture and prevent escape of such severed tissue.
- suction or negative pressure is applied through the lumen of the debulker 14 , 14 a
- the operator may monitor the amount of negative pressure being generated as an indicator of whether the cutting tip 46 , 46 a is presently in contact with tissue. In this manner, the operator may promptly discern when the cutting tip 46 , 46 a has passed fully through the desired tissue and into the opposite blood vessel or other cavernous space.
- an optional sensor apparatus may be incorporated into the system 10 , 10 a to provide feedback or signal(s) to enable the operator to determine when the debulking operation is complete so that the advancement or retraction of the debulker 14 , 14 a may be terminated at an appropriate time.
- the sensor apparatus 126 may comprise any suitable type of sensor which will indicate when the cutting edge 46 of the annular cutting member 42 is no longer in contact with tissue. Examples of the types of sensor apparatus 126 which may be used include sensors which measure impedance, temperature and/or electromagnetic resistance. Additionally, in systems 10 , 10 a which utilize pulsed energy (FIG.
- the temperature sensed by the sensor 126 may be used to manually or automatically (i.e., by a microprocessor or other controller) adjust the duty cycle of the pulsed energy to avoid exceeding a maximum desired temperature (e.g., the thermal necrosis temperature of the tissue—or some other temperature which has been identified as the maximum temperature to which the surrounding tissue may be heated).
- a maximum desired temperature e.g., the thermal necrosis temperature of the tissue—or some other temperature which has been identified as the maximum temperature to which the surrounding tissue may be heated.
- either of the debulking-type systems 10 , 10 a may include a force controlling apparatus 128 for controlling the force applied by the debulker 14 , 14 a upon the tissue being severed.
- the debulker 14 has a flexible tubular shaft 40 formed of a proximal segment 40 a and a distal segment 40 b .
- the distal segment 40 b is slidably received within the lumen of the proximal segment 40 a , as shown.
- the force controlling apparatus 128 comprises a spring 130 which is attached to the proximal and distal portions 40 a , 40 b of the tube 40 such that, when the distal end of the debulker 14 is pressed against tissue, the spring 130 will compress, thereby normalizing or regulating the force which is applied to the tissue.
- the debulker emits energy (e.g., radiofrequency energy, resistance heat) first and second energy-transmission contacts 132 , 134 such that energy will be emited from the debulker only when the contacts 132 , 134 are in abuttment with each other.
- energy e.g., radiofrequency energy, resistance heat
- FIGS. 12 - 12 c show a dilation-type tract enlarging system 10 b of the present invention.
- This dilation-type system 10 b generally comprises a) a tubular member 120 having a distal tissue-abutting rim 122 , and a lumen 124 extending longitudinally therethrough and b) a shaft 126 having a balloon 128 mounted thereon, a guidewire lumen 130 extending longitudinally therethrough, and an inflation/deflation lumen 132 extending from the proximal end thereof to the interior of the balloon.
- a guidewire which has previously been passed through the penetration tract which is to be enlarged, is inserted into the distal end of the guidewire lumen 130 .
- the system 10 b is advanced over the guidewire GW until the tissue abutment rim 122 abuts against or otherwise registers with tissue which surrounds or lies adjacent the proximal end of the penetration tract.
- tissue abutment rim 122 abuts against or otherwise registers with tissue which surrounds or lies adjacent the proximal end of the penetration tract.
- inflation fluid is passed into the balloon 128 through the inflation/deflation lumen 132 , causing the balloon 128 to inflate.
- inflation of the balloon serves to dilate the tissue surrounding the penetration tract, thereby accomplishing the desired enlargement of the penetration tract.
- the inflation fluid may be withdrawn from the balloon 128 and the system 10 b is withdrawn from the body.
- FIGS. 17 - 18 b show tissue-cutting tract enlarging catheters 10 c of the present invention.
- These tissue cutting catheters 10 c comprise a flexible catheter 700 having a tissue cutting distal tip 702 a or 702 b mounted thereon.
- the tissue cutting distal tip 702 a is a generally cylindrical solid member which has a has a beveled leading edge 704 and a guidewire lumen 706 a extending longitudinally therethrough, as shown.
- the tissue cutting distal tip 702 b has two (2) tapered lateral surfaces 709 a , 709 b which converge to form a distal end 710 .
- a central guidewire lumen 706 b extends through the distal end 710 , as shown.
- tissue cutting catheters 10 c may be advanced over a guidewire and through a small penetration tract, such that the beveled distal edge 704 or lateral surfaces 706 a & 706 b will slice or slit the tissue without actually removing any tissue.
- FIG. 19 shows a two-catheter tract enlarging system 10 d which comprises comprises a) a first catheter 500 having a tract-enlarging apparatus (not shown) (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) advancable from an opening 504 at or near the distal end of the first catheter 500 , and b) a second catheter 502 which has an anvil member 506 (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter.
- a tract-enlarging apparatus not shown
- anvil member 506 e.g., an abuttable surface or receiving cavity
- the first catheter 500 is positioned in one of the anatomical conduits V, and the second catheter is positioned in the other anatomical conduit A, with its anvil member 506 located next to the penetration tract or passageway PT which is to be enlarged. Thereafter, the tract enlarging apparatus (not shown) is advanced through the tract or passageway PT until it registers with (e.g., abutts against or is received with) the anvil member 506 of the second catheter.
- the anvil member 506 serves to provide counterforce against the tissue adjacent the initially formed tract or passageway PT so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit A, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.
Abstract
Methods, apparatus and systems for enlarging interstitial penetration tracts which have been formed between blood vessels or elsewhere within the body of a mammalian patient. Included are debulking-type tract enlarging systems, dilation-type tract enlarging systems, tissue-slicing-type tract enlarging systems and two-catheter-type tract enlarging systems.
Description
- The present invention relates generally to medical devices and methods, and more specifically to transluminal devices, systems and methods which are useable to enlarge interstitial tracts (e.g., man made puncture tracts or small passageways) which extend between two (2) anatomical conduits (e.g., blood vessels) or otherwise through tissue(s) within a mammalian body.
- Applicant has devised several new medical procedures wherein passageway-forming catheters are advanced into anatomical conduits (e.g., blood vessels) and are used to create one or more interstitial passageways which extend outwardly, from the conduit in which the catheter is positioned, to another conduit or anatomical structure. Some of these procedures may be used to form flow-through passageways between the anatomical conduit (e.g., blood vessel) in which the passageway-forming catheter is positioned, and another anatomical conduit (e.g., another blood vessel) or a different location on the same anatomical conduit (e.g., a downstream site on the same blood vessel). Alternatively, these procedures may be used to form access passageways between the anatomical conduit (e.g., blood vessel, urethra, fallopian tube, etc..) and another anatomical structure (e.g., a tumor, organ, muscle, nerve, etc.).
- In at least some of applicant's procedures, the interstitial passageway(s) are initially formed by advancing a tissue-penetrating element (e.g., a small diameter needle or a flow of tissue-penetrating energy) from the passageway-forming catheter, through the wall of the anatomical conduit in which the catheter is positioned, and into the target location. In some cases, the interstitial passageway which is formed by the initial passage of the tissue-penetration element from the passageway-forming catheter is of relatively small diameter—and must subsequently be enlarged (e.g., debulked, dilated, expanded, stretched) to accommodate the desired flow of biological fluid (e.g., blood) or passage of other substances/ devices therethrough.
- In particular, as described in applicant's earlier-filed U.S. patent applications Ser. No. 08/730,327 and 08/730,496, such enlargement of the initially formed interstitial passageway (e.g., penetration tract) may be particularly important when the procedure is being performed to by-pass an obstruction within a coronary artery. For example, in some of applicant's procedures, a primary interstitial passageway is formed between an obstructed coronary artery and an adjacent coronary vein, such that blood will flow from the obstructed artery into the adjacent coronary vein. In such applications, the arterial blood which enters the adjacent coronary vein through the primary interstitial passageway is allowed to retroperfuse the ischemic myocardium by retrograde flow through the coronary vein. In other of applicant's procedures, one or more secondary interstitial passageways are formed between the coronary vein into which the arterial blood has flowed and the obstructed artery (or some other coronary artery) to allow arterial blood which has entered the coronary vein to reenter the obstructed artery (or some other coronary artery), after having bypassed the arterial obstruction. Thus, in either of these interventional procedures, it is important that the primary and/or secondary interstitial passageway(s) remain patent and sufficiently large in diameter to support the continued flow of arterial blood to the myocardium. However, the task of enlarging the small diameter interstitial passageway(s) (e.g., puncture tracts) formed by the initial passage of the tissue-penetrating element presents numerous technical challenges.
- Although the prior art has included a number of catheter-based devices which may be used to enlarge or remove obstructive matter from the lumen of a blood vessel or other anatomical conduit (e.g., a blood vessel). These devices include; atherectomy catheters, embolectomy catheters, balloon angioplasty catheters, laser ablation catheters, etc. However, these prior art lumen-enlarging/lumen-clearing devices have typically not been intended for use in small diameter puncture tracts which diverge at an angle from the conduit lumen in which the catheter is located, as is typically the case in applicant's above-summarized interventional procedures.
- Accordingly, there exists a need for the design and development of a new device, system and method for enlarging interstitial penetration tracts (e.g., man-made punctures or small passageways) which extend between adjacent anatomical conduits (e.g., blood vessels) within a mammalian body.
- The present invention provides devices which are useable in combination with each other (i.e., as a system) to enlarge an interstitial tract (e.g., a small diameter penetration tract through tissue) which extends from a blood vessel or other anatomical conduit of the body. The devices and systems of the present invention generally fall into three (3) major classifications—1) debulking-type tract enlargement systems, 2) dilating-type tract-enlargement systems, and 3) slicing-type tract enlargement systems.
- In accordance with the invention, one debulking-type tract enlargement system (referred to herein as an “advancable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough; b) a counter-traction member which is advanceable, i.) through the lumen of the tubular sheath and ii.) at least partially through the interstitial tract, such that the countertraction member engages or becomes positioned in relation to tissue which lies adjacent the interstitial tract to thereafter exert proximally-directed force upon such tissue; and, c) a debulker (e.g., a tissue removing apparatus or flow of energy) which is advanceable out of the lumen of the sheath in a distal direction (i.e., substantially opposite the proximally-directed force being exerted by the counter-traction member) to remove tissue from the area adjacent the tract.
- Further in accordance with the invention, there is provided another debulking-type tract enlargement system (referred to herein as a “retractable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a pull-back debulker (e.g., a tissue-removing apparatus or flow of energy) which is i.) initially advanceable out of the lumen of the sheath in a distal direction so as to pass through the penetration tract which is to be enlarged, and ii.) thereafter retractable in the proximal direction so as to remove tissue which lies adjacent the interstitial tract, thereby enlarging the interstitial tract.
- Still further in accordance with the invention, there is provided a dilating-type tract enlargement system (referred to herein as a “dilating” system) which generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a dilator (e.g., an elongate member) having at least one tissue-dilating member (e.g., a tapered, frusto-conical member, balloon or radially deployable member(s)) formed thereon, such dilator being advanceable into the penetration tract which is to be enlarged, and is subsequently useable to dilate such penetration tract, thereby resulting in the desired enlargement thereof. A positioning surface may be formed on the dilator to abut against tissue which lies adjacent the passageway in a manner which will enable the operator to determine that the dilator has been advanced to its desired position and is properly located to allow the dilate the interstitial tract as desired.
- Still further in accordance with the invention, there is provided a slicing-type tract enlargement system (referred to herein as a “tissue-slicing” system) which generally comprises a) an elongate shaft which is advanceable through the interstitial tract, and b) at least one tissue slicing member which extends or is extendable from the shaft to incise or cut tissue which lies adjacent the interstitial tract as the shaft is advanced and/or retracted through the tract. In some embodiments, the tissue slicing member(s) may be initially disposed in a radially compact configuration which is flush with, or only slightly protrusive beyond, the outer surface of the shaft, thereby allowing the shaft to be advanced through the interstitial tract without cutting or disrupting the surrounding tissue. Thereafter, the tissue slicing member(s) is/are shifted to a radially expanded configuration wherein such tissue-slicing member(s) extend or protrude laterally from the shaft so as to slice, incise or cut at least some of the tissue which surrounds the tract. The tissue-slicing member(s) need not be concentric about the shaft, but rather may be of substantially flat configuration so as to create a defined incision or cut in the tissue. Moreover, the tissue-slicing member(s) may be configured so as not to completely sever and remove tissue in the manner of the above-sumarized debulking-type embodiment, but rather may simply form a slit or incision adjacent the tract such that the surrounding tissue will continuously or intermittantly separate to allow flow of fluid (e.g., blood) therethrough.
- Still further in accordance with the invention, there is provided a two-catheter type tract enlarging system (referred to herein as a “two-catheter” system) which is specifically useable to enlarge an interstitial tract or passageway which has been formed between two adjacent anatomical conduits (e.g., blood vessels). Such two-catheter system generally comprises a) a first catheter having a tract-enlarging apparatus (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) which is advancable from an opening at or near the distal end of that catheter, and b) a second catheter which has an anvil member (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter. The first catheter is positioned in one of the anatomical conduits, and the second catheter is positioned in the other anatomical conduit, with its anvil member located next to the interstitial tract or passageway which is to be enlarged. Thereafter, the tract enlarging apparatus is advanced through the tract or passageway until it registers with (e.g., abutts against or is received with) the anvil member of the second catheter. As the tract enlarging apparatus is being advanced, the anvil member serves to provide counterforce against the tissue adjacent the initially formed tract or passageway so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.
- Still further in accordance with the invention, either the debulking-type, dilating type, tissue-slicing type or two catheter type tract enlargement systems of the present invention may incorporate a guidewire lumen which extends longitudinally through the i.) tract enlarging member (e.g., debulker, dilator or tissue slicing member) to permit the tract enlarging member to be advanced over a small guidewire which has previously been passed through the penetration tract which is to be enlarged. Thus, the provision of such guidewire lumen may permit the system to be used to dilate penetration tracts which are of extremely small diameter, or which have become substantially closed off due to constriction of the surrounding tissue, provided that a guidewire was previously inserted through such penetration tract.
- Still further in accordance with the invention, energy such as radio-frequency energy or electrical resistance heat may be applied to the tract enlarging member (e.g., debulker, dilator, or tissue slicing member) to enhance the tract-enlarging efficiency thereof.
- Still further objects and advantages of the present invention will become apparent to those of skill in the relevant art, upon reading and understanding of the following detailed description of the invention and the accompanying drawings.
- FIG. 1 is a perspective view of a debulking-type tract enlarging system of the present invention.
- FIG. 2 is a schematic perspective view of a human body having the tract enlarging system of FIG. 1 operatively inserted into the coronary vasculature.
- FIG. 2a is an enlarged, cut-away view of segment 2 a-2 a of FIG. 2.
- FIG. 3 is an enlarged sectional view through line3-3 of FIG. 2a.
- FIGS. 3a-3 d are step-wise showings of a presently preferred method for using the tract enlarging system of FIG. 1 to debulk and enlarge an interstitial penetration tract which has been created between a coronary artery and an adjacent coronary vein.
- FIG. 4 is an enlarged, side elevational view of the distal portion of the tract enlarging system of FIG. 1.
- FIG. 4a is a cross sectional view through line 4 a-4 a of FIG. 4.
- FIG. 4b is a cross sectional view through line 4 b-4 b of FIG. 4.
- FIG. 4c is a cross sectional view through
line 4 c-4 c of FIG. 4. - FIG. 5a is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
- FIG. 5b is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
- FIG. 6 is a is a longitudinal sectional view of the distal portion of the subselective sheath component of the system of FIG. 1.
- FIG. 7 is a is a longitudinal sectional view of the distal portion of the tissue cutter component of the system of FIG. 1.
- FIG. 7a is an exploded, longitudinal sectional view of the distal potion of the tissue cutter of FIG. 7.
- FIG. 8 is a side elevational view of the counter-traction member component of the system of FIG. 1.
- FIG. 8a is an exploded, longitudinal sectional view of the distal potion of the counter-traction member of FIG. 8
- FIG. 9a shows a first alternative counter-traction member having a tissueengaging member formed of radially expandable members, wherein the radially expandable members are in their collapsed configuration.
- FIG. 9b shows the first alternative counter-traction member of FIG. 9a, with its radially expandable members in a partially expanded configuration.
- FIG. 9c shows the first alternative counter-traction member of FIG. 9a, with its radially expandable members in their fully expanded configuration.
- FIG. 10a is a side elevational view of a debulking-type tract enlarging system which is equipped with a first type of an energy emitting debulker (e.g., a radio-frequency system).
- FIG. 10b is an enlarged perspective view in the distal end of the energy-emitting debulker of FIG. 10.
- FIG. 10c is a cross sectional view through line 10 c-10 c of FIG. 10a.
- FIG. 10d is a side elevational view of the distal portion of an another alternative debulking-type system which comprises an energy-emitting debulker in conjunction with an energy emitting counter-traction member, and wherein the energy emitting counter-traction member is in a retracted position.
- FIG. 10e shows the system of FIG. 10 c with its energy-emitting countertraction member in its extended position.
- FIG. 10f is a cross sectional view through
line 10 e-10 e of FIG. 10d. - FIG. 10g is a side elevational view of the distal portion of another energy-emitting debulker which incorporates an annular array of laser-transmitting optical fibers.
- FIG. 10g′ is a distal end view of the debulker of FIG. 10g.
- FIG. 10h is a side elevational view of the distal portion of another energy-emitting debulker which incorporates a central laser-transmitting optical fiber (or fiber bundle) in combination with a prism which disseminates the laser light in an annular array to effect the desired severing or vaporization of tissue.
- FIG. 11a shows a debulking-type tract enlarging system having an advanceable debulker and a second alternative counter-traction member having a tissue-engaging member formed of an inflatable balloon, wherein the inflatable balloon is in its non-inflated, collapsed configuration.
- FIG. 11b is a cross sectional view through line 11 b-11 b of FIG. 11a.
- FIG. 11c shows the second alternative counter-traction member of FIG. 11a, with its balloon in a fully inflated, expanded configuration.
- FIG. 11d shows the second alternative countertraction member of FIG. 11a, with its balloon in its fully inflated, expanded configuration and the shaft fully retracted into the lumen of the debulker.
- FIG. 11e shows a debulking-type tract enlarging system having an advanceable debulker and a third alternative counter-traction member which comprises a plurality of outwardly splayable tissue-engaging members, wherein the tissue-engaging members are in there radially collapsed configuration and the counter-traction member is only slightly advanced out of the debulker.
- FIG. 11f shows the system of FIG. 11e wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member is being further advanced out of the debulker.
- FIG. 11g shows the system of FIG. 11f wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member is fully advanced out of the debulker.
- FIG. 11h shows the system of FIG. 119 wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member has been fully retracted such that the distal end of the debulker engages the interior of the expanded tissue-engaging members.
- FIG. 12a is a side elevational view of the distal portion of a retractable debulking-type tract enlarging system of the present invention, wherein the retractable debulker is disposed in a distally extended position.
- FIG. 12b is a view of the system of FIG. 12A, wherein the debulker is disposed in a partially retracted position.
- FIG. 13 is a side elevational view of a dilation-type tract enlarging system of the present invention, disposed with its dilator (i.e. balloon) in a stowed (i.e., deflated) position.
- FIG. 13a is view of the system of FIG. 13, disposed with its dilator (i.e., balloon) in an operative (i.e., inflated) position.
- FIG. 13b is a cross sectional view through
line 13 b-13 b of FIG. 13. FIG. 13c is a cross sectional view through line 1 3 c-1 3 c of FIG. 13. - FIG. 14 is a graphic illustration of a continuous emission of radiofrequency energy in accordance with the present invention.
- FIG. 15 is a graphic illustration of intermittant or pulsed emission of radiofrequency energy in accordance with the present invention.
- FIG. 16 is a longitudinal sectional view of the distal portion of a debulker of the present invention which incorporates an apparatus for controlling the pressure appplied by the debulker and/or for signifying when the debulking procedure is complete.
- FIG. 17 is a side elevational view of the distal portion of a tissue-cutting type of tract enlarging system of the present invention.
- FIG. 18a is a side elevational view of an alternative tissue-cutting tip for the system of FIG. 17.
- FIG. 18b is a top plan view of the alternative tissue-cutting tip of FIG. 18a.
- FIG. 18c is a distal end view of the alternative tissue cutting tip of FIG. 18a.
- FIG. 19 is a schematic showing of two adjacent blood vessels having a penetration tract formed therebetween, and a two-catheter tract enlarging system of the present invention operatively disposed therein to enlarge the penetration tract.
- The preferred embodiments and examples described in the following paragraphs, and shown in the accompanying drawings, should be considered as exemplars, rather than limitations on the devices, systems and methods of the present invention.
- The particular embodiments described in detail below include debulking-type
tract enlargeing systems tract enlargement systems 10 b, and tissue-slicing-type tract enlarging systems 10 c. - A. Debulking-Type Systems
- Generally, the debulking-
type systems type system 10 as well as a proximally retractable debulking-type system 10 a. - 1. Advanceable Debulking-type Systems
- FIGS.1-9 show a preferred, distally-advanceable debulking-type
tract enlargeing system 10 which is useable to enlarge a penetration tract. As shown in detail in FIGS. 4-8 a, this distallyadvanceable debulking system 10 generally comprises a) asubselective sheath 12, b) a distally-advanceable debulker 14 which is passable out of the subselective sheath, in a distal direction DD, and acounter-traction member 16 which is advanceable through the penetration tract ahead of thedebulker 14, and engageable with tissue adjacent the tract to exert a counter-force (i.e. a force directed in the proximal direction PD) upon the tissue which is to be severed by thedistally advancing debulker 14. It is also to be understood that thecounter-traction member 16 may simily be positioned adjacenyt the tissue such that it does not actually exert force against the tissue until thedebulker 14 is advanced into contact with the tissue, at which time the tissue will then be compressed between the debulker and thecounter-traction member 16 as the debulking procedure is performed. - The
subselective sheath 12 of the embodiment shown in the drawings comprises a flexible tube which is sized to be advanceable into the anatomical conduit from which the interstitial penetration tract extends. With particular reference to the showings of FIG. 4, 4 c and 6, thepreferred subselective sheath 12 comprisesinner wall 30 preferably formed of formed of polytetrafluoroethylene (PTFE), anouter wall 32 preferably formed of polyether block amide polymer (e.g., Pebax™), and abraid 34 captured between inner 30 and outer 32 walls,such braid 34 terminating distally at a location which is approximately 2-10 mm from the distal end of thesheath 12. In this manner, there is defined a non-braideddistal portion 36 of approximately 2-10 mm and a braidedproximal portion 38. The presence of thebraid 34 within theproximal portion 38 of thesheath 12 enhances its strength and resistance to crimping or kinking, while the non-braideddistal portion 36 of thesheath 12 remains soft and pliable to avoid injury or damage to the walls of blood vessels or other tissues, as thesheath 12 is advanced. For use in coronary blood vessels, thesheath 12 will preferably have an outer diameter of 0.050-0.150 inch and an inner lumen diameter of 0.040-0.140 inch. - In some embodiments, the
subselective sheath 12 may have lumen which curves laterally and exits through an outlet port formed in the sidewall of thesheath 12. Such side outlet sheath (not shown) may be advanced to a position where the side outlet aperture is in direct alignment with the penetration tract PT which is to be enlarged. Thereafter, thedebulker 14 may be advanced out of the side outlet aperture and directly through tissue which surrounds the penetration tract PT. - The
debulker 14 of the embodiment shown in the drawings comprises a rotating tissue cutter which, when advanced in the distal direction and concurrently rotated, will sever and remove a cylindrical mass of tissue which surrounds the penetration tract. With particular reference to the showings of FIGS. 7 and 7a, thispreferred debulker 14 comprises aflexible tube 40 which has alumen 44 extending longitudinally therethrough, and anannular cutting member 42 mounted on the distal end thereof. Theannular cutting member 42 has a sharpened leadingedge 46 and ahollow bore 48 which extends therethrough. The cuttingmember 42 is mounted securely on the distal end of the tube, preferably such that thebore 46 of theannular cutting member 42 is in direct axial alignment with thelumen 44 of thetube 40, and the outer surface of the cuttingmember 42 is flush with the outer surface of thetube 40. Thetube 40 is preferably formed of a flexible plastic such as polyether block amide polymer (e.g., Pebax™) and thecutter member 42 is preferably formed of a rigid material such as stainless steel. In embodiments intended for use in coronary blood vessels, thisdebulker 14 will preferably have an outer diameter of 0.05-0.13 inches and an inner (lumen) diameter of 0.04-0.12 inches. A plurality of bearingmembers 50 may be mounted at spaced-apart locations within thelumen 44 of thedebulker 14 to facilitate rotation of the debulker 41 about a central shaft (e.g., theshaft 60 of the countertraction member 16). A drive motor/handpeice 22 may be mounted on the proximal end of thedebulker 14, as shown in FIGS. 1 and 7. This drive motor/handpeice 22, when actuated, will rotationally drive thedebulker 14, at a suitable rate of rotation to facilitate the desired severing of tissue. In applications where thedebulker 14 is being used to sever soft tissue, it is preferable that the motor/handpeice 22 be capable of driving thedebulker 14 at 60-300 revolutions per minute. One example of a commercially available drive motor/handpeice 22 which may be used is the MDV Motor Drive Unit manufactured by DVI , Inc. - The
counter-traction member 16 of the embodiment shown in the drawings serves to pass through the interstitial tract to be enlarged, ahead of the debulker, and prevents unwanted protrusion or “tenting” of the tissue into the adjacent anatomical conduit, thereby enhancing the tissue cutting efficience of the debulker. With particular reference to the showings of FIGS. 4, 4a, 8 and 8 a, thepreferred counter-traction member 16 comprises an elongate,pliable shaft 60 having a dilator/tissue-engagingmember 62 mounted on the distal end thereof, and aguidewire lumen 67 . The tract dilator/tissue engaging member 62 comprises afrustoconical body 68 and a cutting-engagement plate 64 formed on the proximal end thereof. Theproximal surface 66 of the cutting-engagement plate 64 is disposed in a plane P which is substantially perpendicular to the longitudinal axis LA of theshaft 60. The frustoconical portion is preferably formed of soft plastic such as polyether block amide polymer (e.g., Pebax™) and the cutting/engagement plate 64 is preferably formed of hard material such as polycarbonate or stainless steel. As shown in the exploded view of FIG. 8a, acavity 73 may be formed in the proximal end of the dilator/engagement plate 62, including ashaft receiving portion 74 and anannular groove 70. Thedistal portion 65 of the cutter/engagement plate 64 is inserted intocavity 73 such that anannular shoulder 72 formed about theproximal portion 65 will frictionally engage a correspondingannular groove 70 formed about the interior of thecavity 73, thereby holding the cutting/engagement plate 64 in fixed position on the distal end of the dilator/engagement member 62. The distal end of theshaft 60 is then inserted through thebore 67 of the cutting/engagement plate 64 until it bottoms out in theshaft receiving portion 74 of thecavity 73. An adhesive or thermal compression bonding may be used to securely hold the shaft in contact with the dilator/engagement member 62. Additionally or alternatively, theproximal portion 65 of the cutting/engagement plate 64 may act as a ferrule, exerting radial inward pressure against the shaft to frictionally hold the shaft in its inserted position within the cavity. Thecounter-traction member 16 also acts to protect the adjacent vessel or luminal anatomical structure from iatrogenic trauma (e.g., perforation, laceration) as the debulker is advanced. - It is to be appreciated that various other types of tissue-engaging members may be utilized in addition to, or as an alternative to the
particular counter-traction member 16 shown in FIGS. 1-8. Some examples of alternative types ofcountertraction members 16 a, 16 b, 16 c are shown in FIGS. 9a-9 c and 11 a-11 h. - With reference to FIGS. 9a-9 c one alternative counter-traction member 16 a comprises a
telescoping shaft 80 formed of adistal shaft portion 80′ and aproximal shaft portion 80″, having a plurality of radiallyexpandable members 82 disposed about theshaft 80, as shown. Preferably, a guidewire lumen (not shown) extends longitudinally through theshaft 80. Each radiallyexpandable member 82 has a distal end which is affixed to thedistal shaft portion 80′ and a proximal end which is affixed to theproximal shaft portion 80″. As shown in FIG. 9a, when thedistal shaft portion 80′ is fully advanced in the distal direction, the radially expandable members will be in a radially collapsed configuration of diameter D, which is sufficiently small to be advanceable through the previously formed penetration tract. Thereafter, as shown in FIGS. 9b and 9 c, thedistal shaft portion 80′ may be retracted into theproximal shaft portion 80″ to cause the radially expandable members to bow or expand outwardly. Thus, when thedistal shaft portion 80′ is partially retracted the radiallyexpandable members 82 may assume a partially expanded configuration of diameter D2 when thedistal shaft member 80′ is fully retracted the radiallyexpandable members 82 will assume a fully expanded configuration of diameter D3. - Referring to FIGS. 11a-11 d, another
alternative counter-traction member 16 b comprises anelongate shaft 90 which has aguidewire lumen 92 and a balloon inflation/deflation lumen 94 extending therethrough, and aballoon 96 mounted thereon. With the balloon in its deflated state as shown in FIG. 1 Oa, theshaft 90 is advanceable over a gudewire and through the penetration tract PT which is to be enlarged. After theballoon 96 has emerged out of the opposite end of the penetration tract PT, inflation fluid is injected through the inflation/deflation lumen 94 to inflate theballoon 96 as shown in FIG. 10c. As described in more detail herebelow, theinflated balloon 96 will the abut against and engage the tissue which surrounds the penetration tract PT, and will exert proximally directed force on such tissue while thedebulker 14 is advanced through the tissue. As shown in FIG. 1 Od, after the tissue has been fully severed, theshaft 90 will be fully retracted into thelumen 44 of thedebulker 14 and the cuttingsurface 46 of theannular cutting member 42 will abut against a reinforcedregion 98 of the balloon. Such reinforcedregion 98 is sufficiently resistant to cutting or puncture to prevent theannular cutting member 42 from bursting or penetrating through the wall of theballoon 96. Referring to FIGS. 11e-11 h, there is shown yet another counter-traction member 16 c which comprises anelongate shaft 150 having a plurality of resilient or spring loaded, outwardlysplayable members 160 which are attached at their distal ends to theshaft 150. The proximal ends of thesplayable members 160 are biased to a radially expanded configuration as shown in figures 11 f-11 h, but are initially compressible to a radially compact configuration wherein they may be receieved within thelumen 44 of the debulker, as shown in FIG. 11e. Initially, with thesplayable members 160 are placed in their radially compact configuration and retracted at least partially within thelumen 44 of thetubular member 40 of thedebulker 14. After the system has been inserted in the body and positioned adjacent the interstitial tract to be enlarged, theshaft 150 is advanced in the distal direction to drive thesplayable members 160 through the interstitial tract. As the proximal ends of the splayable members emerge from the distal end of the interstitial tract, they will spring outwardly to their radially expanded configuration and will engage the tissue adjacent the distal end of the tract. Thereafter, proximally directed pressure may be applied to the shaft as thedebulker 40 is advanced in the distal direction. This resultss in the desired counter-traction on the tissue being severed by theannular cutting member 42. At it end of the tract enlarging procedure, the leadingedge 46 of theannular cutting member 42 will be nested within and in contact with thesplayable members 160, as shown in FIG. 11h. In this manner, as will be more fully appreciated after reading the explanation of the detailed operation of the device set forth herebelow, the tissue which has been severed from the area surrounding the interstitial tract will be received within thelumen 44 of the debulker, for subsequent removal from the body. - Prior to operation, the
system 10 is assembled in the manner shown in FIG. 5a, such that theshaft 60 of thecounter-traction member 16 is slidably and rotatably disposed within thelumen 44 of the debulker 14 (i.e. extending through thebearings 50 located within thelumen 44 of the debulker 14) and thecountertraction member 16 anddebulker 14 are positioned within thelumen 31 of thesheath 12. Thissystem 10 may then be utilized to enlarge a small penetration tract PT which has been formed between an anatomical conduit and some other anatomical conduit or cavity within the body. For purposes of illustrating and explaining the operation of the present invention, FIGS. 3a-3 d show a specific coronary revascularization procedure wherein an interstitial passageway is to be formed between a coronary vein CV and an adjacent coronary artery CA, to permit arterial blood to flow into the coronary vein CV. - With reference to FIGS. 3a-3 d, after an interstitial penetration tract PT has been formed between a coronary artery CA and coronary vein CV, a small guidewire GW is passed through such penetration tract PT. The guidewire GW is passed, proximal end first, into the distal end of the
guidewire lumen 67 which extends through thecounter-traction member 16. With thedebulker 14 andcountertraction member 16 disposed within thelumen 31 of thesubselective sheath 12, thesystem 10 is advanced over the guidewire GW until the distal end of thesubselective sheath 12 becomes positioned within the coronary vein CV at a location approximately 0.10 inch (i.e., 2-3 mm) from the penetration tract PT. Thereafter, as shown in FIG. 3, the counter-traction member is further advanced such that the dilator/engagement member 62 will pass through the penetration tract PT and into the coronary artery CA. As the dilator/engagement member emerges into the lumen of the coronary artery CA the tissue surrounding the penetration tract PT will elastically retract about the distal portion of the shaft and theproximal surface 66 of the cutting/engagement plate 64 will abut against the coronary artery wall immediately adjacent the opening of the penetration tract PT into the coronary artery CA. Thereafter, proximally directed pressure is applied to thecounter-traction member 16 while concurrently advancing thedebulker 14 in the distal direction, as shown in FIG. 3a. As the advancingdebulker 14 comes into contact with the tissue which surrounds the penetration tract PT, the drive motor/handpeice 22 is actuated so as to rotate the debulker at approximately 60-300 RPM. As shown in FIG. 3b, this causes the sharpened leadingedge 46 of the cuttingmember 42 to cut a cylindrical bolus of tissue as the rotatingdebulker 14 continues to advance. The application of proximally directed pressure on thecounter-traction member 16 concurrently with the distally directed advancement of thedebulker 14 prevents the surrounding tissue from “tenting” and enhances the cutting efficiency of thedebulker 14. Also, because the tissue which is being severed is located directly behind the cutting/engagement plate 64, the severed bolus of tissue will be prevented from escaping into the coronary artery CA, and will be forced into the lumen of thedebulker 14 whereby it may be extricated and removed from the body along with thedebulker 14, as illustrated in FIG. 3c. This results in the formation of an enlarged bloodflow passageway EBP, as desired. - As shown in FIG. 3d, and in accordance with applicants methodology described in earlier-filed U.S. patent applications Ser. No. 08/730,327 and 08/730,496, one or more embolic blockers B or other flow-blocking means may be utilized to prevent arterial blood which enters the coronary vein CV through the enlarged bloodflow passageway EBP from flowing in the venous return direction, and to cause such arterial blood to flow through the coronary vein CV in the retrograde direction, thereby bypassing the obstruction OB located in the adjacent coronary artery CA.
- 2. Retractable Debulking-type Systems
- FIGS. 12a-12 b show an example of a retractable debulking-type
tract enlargement system 10 a, of the present invention. Thissystem 10 a comprises aproximal counter-force member 112 in combination with aretractable debulker 14 a, as shown in FIGS. 12a and 12 b. - The
proximal counter-force member 112 comprises a tube having a lumen (not shown) which extends longitudinally therethrough and an annular cutting/engagement plate 100 formed on the distal end thereof. The annular cutting/engagement plate 100 serves to engage a pull-back tissue cutter formed on the proximal end of theretractable debulker 14 a. In embodiments where the retractable debulker is rotatable, a plurality ofbearings 50 of the type described hereabove may be coaxially disposed at spaced apart locations within the lumen of theproximal counter-force member 112. - The
retractable debulker 14 a of this embodiment comprises ashaft 102 having a flexible frusto-conical dilator 104 formed thereon, and anannular cutter member 106 mounted on the proximal end of thedilator 104, as shown. The frusto-conical dilator 104 may be constructed and configured the same as thefrustoconical body 68 described hereabove. Theannular cutting memebr 106 may be constructed and configured the same as theannular cutting member 42 of the first embodiment described hereabove. Thisannular cutting member 106 has a sharpenedproximal edge 108 which will sever tissue when retracted therethrough. A guidewire lumen(not shown) extends longitudinally through theshaft 102 and through the frusto-conical dilator. Optionally, the retractable debulker 1 4 a may be rotatably driven by a drive motor/handpeice 22 as described hereabove. - Prior to operation, this retractable debulking type system1 Oa is assembled such that
shaft 100 theretractable debulker 14 a is slidably and (and in some cases rotatably) disposed within the lumen of theproximal counter-force member 112. In embodiments wherein the debulker 14 a is rotatable, theshaft 102 will extend through anybearings 50 disposed within the lumen of thecounter-force member 112. Theshaft 102 may initially be retracted such that the proximal sharpenededge 108 of theannular cutter 106 is in abutment with theannular cutting plate 100. The counter-force member 1 12 andretractable debulker 14 a are positioned within thelumen 31 of asubselective sheath 12 as described hereabove. This system 1 Oa may then be utilized to enlarge a small penetration tract PT which has been formed through the sidewall of and extending outwardly from an anatomical conduit of the body, and through which a guidewire has been inserted. - The guidewire GW which extends through the penetration tract is inserted into the distal end of the guidewire lumen (not shown) of the
retractable debulker 14 a. Thesubselective sheath 12 having thecounterforce member 112 and retractable debulker positioned therewith, is maneuvered into the anatomical conduit from which the penetration tract extends. Thereafter, theshaft 102 of theretractable debulker 14 a is advanced such that thedilator 104 is forced through the penetration tract. After the sharpenedproximal edge 108 of theretractable debulker 14 a has emerged out of the opposite end of the penetration tract, the tissue which surrounds the penetration tract will elastically constrict about the shaft. Thecounter-force member 112 is then advanced until the distalannular cutting plate 100 is in abutment with the wall of the portion of the wail of the anatomical conduit which surrounds the proximal end of the penetration tract. - Thereafter, distally directed counter-force is applied to the
counter-force member 112 while theretractable debulker 14 a is retracted in the proximal direction. Optionally, theretractable debulker 14 a may be rotated concurrently with its retraction. As the debulker 14 a is retracted, the sharpenedproximal edge 108 of theannular cutting member 106 will sever a generally cylindrical bolus of tissue which surrounds the puncture tract, thereby accomplishing the desired enlargement of the initially formed penetration tract. The severed bolus of tissue will be drawn into, and captured within, the lumen (not shown) of thecounter-force member 112 as the sharpenedproximal edge 108 of theannular cutting member 106 is retracted into contact with theannular cutting plate 100. - Thereafter, the counter-force member112 (having the severed bolus of tissue contained therewithin) and the
retractable debulker 14 a, may be removed from the body along with thesubselective sheath 12. - 3. Sizing and Shaping of the Debulker to Optimize Flow Channel
- In ether
debulking type system cutter member 42 can assist in creation of the optimal passage, such as the enlarged bloodflow passageway EBP of the foregoing example. For example, theannular cutting member 42 need not be of circular cross-sectional configuration as shown in FIG. 7a, but rather may be of oblong or oval configuration. Such oblong or oval shape of theannular cutting member 42, when advanced through the puncture tract without rotation thereof, will form a channel of oval or oblong cross-sectional shape. - Also, as shown on FIG. 4, the
annular cuttiong member 42 may be of tapered outer diameter, such that its distal cutting edge is of a first diameter dx and its proximal end is of a second diameter dy. Such tapering of theannular cutting member 42 causes the tissue which is cut by thecutting edge 46 to expand as thedebulker 14 is advanced, thereby resulting in a more predictable diameter of the resultant channel. - 4. Optional Energy-delivery Features which may be Incorporated into Any of these Tract-Enlarging Systems
- It will be appreciated that certain types of energy (e.g., laser, radio-frequency energy, electrical resistance heat, etc.) may be delivered to a tract-enlarging apparatus such as the
debulker counter-traction member 16, 16 a, 16 c to enhance the tract-enlarging efficiency of the system. Specific examples of systems which incorporate such energy emitting components are shown in FIGS. 10a-10 f. - FIGS. 10a-10 c show one energy-emitting debulking-type system which incorporates a bipolar, energy-emitting
debulker 14′. FIGS. 10d-10 f show another energy-emitting, debulking-type system one electrode is located on an energy-emittingdebulker 14′″ and another electrode is located on an energy-emittingcounter-traction member 16″. - With reference to the particular embodiment shown in FIGS. 10a-10 c, the bipolar,
radiofrequency debulker 14′ comprises an elongatetubular member 40′ having ahollow lumen 44′ extending longitudinally therethrough. First and second energy-transmittingmembers tubular member 44′, as shown in the cross sectional view of FIG. 10c. Adebulking electrode tip 205 is mounted on the distal end of the tubular member.Such electrode tip 205 incorporates a first radiofrequency-emittingelectrode 206 and a second radiofrequency-emittingelectrode 208, as shown in FIG. 10b. The firstenergy transmitting member 204 a is connected to thefirst electrode 206 and the secondenergy transmitting member 204 b is connected to thesecond electrode 208. Anannular insulator body 210 is disposed between theelectrodes bipolar radiofrequency generator 200 is connected by way of awire 202 to the first and secondenergy transmitting members generator 200 and the respective first andsecond electrodes second electrodes - In the alternative bipolar energy-emitting system shown in FIGS. 10d-10 f, the
first electrode 206 a is mounted on the distal end of thedebulker 14″ and thesecond electrode 208 a is mounted on the proximal end of thecountertraction member 16″, as shown. In this embodiment, the firstenergy transmitting member 204 a extends through thetubular member 40″ of thedebulker 14″ while the secondenergy transmitting member 204 b extends through theshaft 60″ of thecountertraction member 16″. Here again, the firstenergy transmitting member 204 a is connected to thefirst electrode 206 a of the secondenergy transmitting member 204 b is connected to thesecond electrode 208 a. In this manner when abipolar radiofrequency generator 200 is connected to theenergy transmitting members second electrodes electrodes 206 a, 206 b in a manner which cuts or ablates the tissue which surrounds the interstitial tract. - As those skilled in the art will appreciate, although bipolar embodiments are shown in FIGS. 10a-10 f, similar monopolar embodiments may also be devised through the alternate use of a separate antenna or plate electrode wich attaches to the patients body to complete the circuit. Such monopolar embodiments may utilize only a
single electrode 204 or 206 to accomplish the desired cutting or ablation of tissue. - In applications where radiofrequency energy is applied to the
debulker - FIGS. 10g-10 i show variants of a laser emitting debulker 14 b, wherein laser energy is used to cut or vaporize the tissue. The embodiment shown in FIGS. 10g and 10 g′ comprises an elongate flexible member having a
guidewire lumen 73 extending longitudinally therethrough, and a plurality of longitudinally extending, paralleloptical fiber bundles 71 disposed in a generally circular array about the outer perimeter of the member, suchoptical fiber bundles 71 terminating distally in lenses or otherlaser emitting surfaces 77 such that a generally conical or annular pattern of laser light is projected from the distal end of the debulker 14 b. - FIGS. 10h and 10 h′ show an alternative laser emitting debulker 14 b′ wherein a central laser-transmitting
optical fiber bundle 75 extends longitudnially through a portion of the debulker 14 b′ and terminates proximal to a generallyconical cavity 76 formed in the distal end of the debulker 14 b′. Astationary prism 77 having a plurality oflight guide grooves 78 formed thereabout, is mounted on the distal end of thefiber bundle 75 such that a generally conical pattern of laser light is projected from the prism, through theconical cavity 76 and out of the distal end of the debulker 14 b′. An optional suction lumen 79 may be provided in any of these laser embodiments, to enhance their efficiency (as described more fully herebelow) and/ or to aspirate away any residue or tissue particle which become severed during the procedure. - FIGS. 10i and 10 i′ show another alternative laser emitting debulker 14 b″ wherein the central laser-transmitting
optical fiber bundle 75′ is rotatable, terminates proximal to a generallyconical cavity 76 formed in the distal end of the debulker 14 b′. Astationary prism 77 having a singlelight guide groove 78 formed thereon as shown, is mounted on the distal end of therotatable fiber bundle 75′ such that as laser energuy is passed through theoptical fiber bundle 75′ concurrently with its rotation, a generally conical pattern of laser light will be projected from the rotating prism mounted on the end of therotating fiber bundle 75′, and such laser light pattern will be projected through theconical cavity 76′ and out of the distal end of the debulker 14 b″. - 4. Optional Application of Negative Pressure Through Debulker Lumen
- In either embodiment of the debulking-
type system debulker debulker debulker tip 46, 46 a is presently in contact with tissue. In this manner, the operator may promptly discern when the cuttingtip 46, 46 a has passed fully through the desired tissue and into the opposite blood vessel or other cavernous space. -
- In either debulking-
type system system debulker sensor apparatus 126 may comprise any suitable type of sensor which will indicate when thecutting edge 46 of theannular cutting member 42 is no longer in contact with tissue. Examples of the types ofsensor apparatus 126 which may be used include sensors which measure impedance, temperature and/or electromagnetic resistance. Additionally, insystems temperature sensor 126, the temperature sensed by thesensor 126 may be used to manually or automatically (i.e., by a microprocessor or other controller) adjust the duty cycle of the pulsed energy to avoid exceeding a maximum desired temperature (e.g., the thermal necrosis temperature of the tissue—or some other temperature which has been identified as the maximum temperature to which the surrounding tissue may be heated). - 6. Optional Apparatus for Controlling the Force Applied by the Debulker
- As shown in FIG. 16, either of the debulking-
type systems force controlling apparatus 128 for controlling the force applied by thedebulker debulker 14 has a flexibletubular shaft 40 formed of a proximal segment 40 a and adistal segment 40 b. Thedistal segment 40 b is slidably received within the lumen of the proximal segment 40 a, as shown. Theforce controlling apparatus 128 comprises aspring 130 which is attached to the proximal anddistal portions 40 a, 40 b of thetube 40 such that, when the distal end of thedebulker 14 is pressed against tissue, thespring 130 will compress, thereby normalizing or regulating the force which is applied to the tissue. In embodiments where the debulker emits energy (e.g., radiofrequency energy, resistance heat) first and second energy-transmission contacts contacts debulker 14 is engaging tissue, and when thedebulker 14 emerges into the other vessel of open space, thespring 130 will relax causingcontacts debulker 14 to cease. - B. Dilation-type Systems
- FIGS.12-12 c show a dilation-type
tract enlarging system 10 b of the present invention. This dilation-type system 10 b generally comprises a) atubular member 120 having a distal tissue-abuttingrim 122, and alumen 124 extending longitudinally therethrough and b) ashaft 126 having aballoon 128 mounted thereon, aguidewire lumen 130 extending longitudinally therethrough, and an inflation/deflation lumen 132 extending from the proximal end thereof to the interior of the balloon. A guidewire which has previously been passed through the penetration tract which is to be enlarged, is inserted into the distal end of theguidewire lumen 130. Thereafter, with theballoon 128 in its deflated state (FIG. 12) and the balloon-bearing portion of theshaft 126 positioned ahead of thetissue abutment rim 122, thesystem 10 b is advanced over the guidewire GW until thetissue abutment rim 122 abuts against or otherwise registers with tissue which surrounds or lies adjacent the proximal end of the penetration tract. Such abutment of therim 122 against the tissue at the proximal end of the tract will deter further advancement of thesystem 10 b, and will signify to the operator that theballoon 128 has become positioned within the penetration tract. Thereafter, inflation fluid is passed into theballoon 128 through the inflation/deflation lumen 132, causing theballoon 128 to inflate. Such inflation of the balloon serves to dilate the tissue surrounding the penetration tract, thereby accomplishing the desired enlargement of the penetration tract. After the desired dilation of the penetration tract has been completed, the inflation fluid may be withdrawn from theballoon 128 and thesystem 10 b is withdrawn from the body. - C. Tissue-slicing Type Systems
- FIGS.17-18 b show tissue-cutting tract enlarging catheters 10 c of the present invention. These tissue cutting catheters 10 c comprise a flexible catheter 700 having a tissue cutting
distal tip - In the embodiment shown in FIG. 17, the tissue cutting
distal tip 702 a is a generally cylindrical solid member which has a has a beveled leadingedge 704 and aguidewire lumen 706 a extending longitudinally therethrough, as shown. - In the embodiment shown in FIGS. 18a-18 c, the tissue cutting
distal tip 702 b has two (2) taperedlateral surfaces distal end 710. Acentral guidewire lumen 706 b extends through thedistal end 710, as shown. - These tissue cutting catheters10 c may be advanced over a guidewire and through a small penetration tract, such that the beveled
distal edge 704 orlateral surfaces 706 a & 706 b will slice or slit the tissue without actually removing any tissue. - D. Two Catheter Tract-Enlarging Systems
- FIG. 19 shows a two-catheter tract enlarging system10 d which comprises comprises a) a
first catheter 500 having a tract-enlarging apparatus (not shown) (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) advancable from an opening 504 at or near the distal end of thefirst catheter 500, and b) asecond catheter 502 which has an anvil member 506 (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter. Thefirst catheter 500 is positioned in one of the anatomical conduits V, and the second catheter is positioned in the other anatomical conduit A, with itsanvil member 506 located next to the penetration tract or passageway PT which is to be enlarged. Thereafter, the tract enlarging apparatus (not shown) is advanced through the tract or passageway PT until it registers with (e.g., abutts against or is received with) theanvil member 506 of the second catheter. As the tract enlarging apparatus (not shown) is being advanced, theanvil member 506 serves to provide counterforce against the tissue adjacent the initially formed tract or passageway PT so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit A, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used. - Although exemplary embodiments of the present invention have been showr and described, it will be apparent to those having ordinary skill in the art that c number of changes, modifications, or alterations to the invention as describer herein may be made, none of which depart from the spirit of the present invention All such changes, modifications and alterations should therefore be seen as withir the scope of the present invention as described herein and recited in the following claims.
Claims (39)
1. An advanceable debulking system for enlarging an interstitial tract which extends outwardly from the lumen of an anatomical conduit, said system comprising:
a counter-traction member which is advanceable, in a first direction, at least partially through the interstitial tract, said counter-traction member having at least one tissue engagement surface formed thereon to engage tissue which is adjacent the interstitial tract, said counter-traction member being useable to apply a force which is directed in a second direction substantially opposite said first direction, upon the tissue which has been engaged by said tissue-engagement member; and,
a debulker which is advanceable out of the lumen of the sheath, in the first direction, to remove tissue which lies adjacent the interstitial tract, thereby enlarging the interstitial tract.
2. The system of claim 1 wherein the debulker is an elongate member having a lumen which extends longitudinally therethrough, and wherein said counter-traction member extends coaxially through the lumen of the debulker.
3. The system of claim 1 wherein the debulker has a distal end, and wherein a tissue-receiving chamber is formed in the distal end of the debulker such that tissue which has been removed by the debulker will enter said tissue-receiving chamber.
4. The system of claim 1 wherein a guidewire lumen extends through said counter-traction member such that said counter-traction member may be advanced over a guidewire which extends through the interstitial tract.
5. The system of claim 1 further comprising a sheath having a lumen extending longitudinally therethrough, the lumen of said sheath being sized to permit said debulker and said countertraction member to pass therethrough.
6. The system of claim 5 wherein said sheath has a distal end opening out of which said debulker and said countertraction member are passable.
7. The system of claim 6 wherein said sheath has a side opening out of which said debulker and said countertraction member are passable.
8. The system of claim 7 wherein the lumen of the sheath further comprises a deflector surface which is configured and located to deflect said debulker out of said side opening as said debulker is advanced in the distal direction therethrough.
9. The system of claim 1 wherein said debulker comprises an elongate member having a distal end whereupon an annular cutter is mounted, said annular cutter having a sharpened leading edge so as to sever tissue as it is advanced in the first direction.
10. The system of claim 9 wherein at least the annular cutter of said debulker is rotatable.
11. The system of claim 9 further comprising a motor for rotatably driving at least the annular cutter of said debulker.
12. The system of claim 1 wherein said countertraction member comprises an elongate shaft having a radially expandable tissue-engaging apparatus formed thereon, said radially expandable tissue-engaging apparatus having:
a) a radially collapsed configuration which is sufficiently small in diameter to pass at least partially through the interstitial tract; and,
b) a radially expanded configuration which is sufficiently large in diameter to engage tissue which surrounds the interstitial tract.
12. The system of claim 11 wherein said radially expandable apparatus is selected from the group of radially expandable apparatus consisting of:
i.) a balloon;
ii.) at least one barb;
iii.) at least one hook;
iv.) a plurality of outwardly curving tissue engagement members, each of said having proximal and distal ends which are attached to the shaft and outwardly curving mid-sections, the mid sections of said tissue engagement members being curved outwardly from said shaft when said
v.) a plurality of splayable tissue engagement members having distal ends which are unattached to the shaft of the counter-traction member and positioned at spaced apart locations thereabout, the distal ends of said tissue engagement members being splayable outwardly from the shaft when in their radially expanded configuration;
and,
vi.) a resilient tubular member which has a radially flared distal end, the flared distal end of said resilient tubular member being advanceable, in the first direction, from the distal end of the shaft of said counter-traction member.
13. The system of claim 1 wherein the debulker further comprises: at least one energy-transmitting member which may be connected to an energy source, said energy transmitting member being operative to transmit energy from an energy source connected thereto, to a location on the debulker at which said energy will enhance the ability of the debulker to remove tissue.
14. The system of claim 13 wherein the energy-transmitting member is a member which transmits radio-frequency energy.
15. The system of claim 14 further comprising: a radio-frequency generator attached to said energy-transmitting member.
16. The system of claim 14 wherein said debulker is an elongate member which has a tissue-severing surface formed on the distal end thereof, and wherein the energy-transmitting member is positioned and constructed to transmit radiofrequency energy to the tissue-severing surface of the debulker.
17. The system of claim 16 wherein the tissue-severing surface comprises a leading edge formed on an annular cutting member.
18. The system of claim 1 further comprising: A dilator formed on the distal end of said counter-traction member to dilate the interstitial tract as the counter-traction member is advanced therethrough.
19. The system of claim 18 wherein the dilator is a frusto-conical dilator member having a distal end of a first diameter and a proximal end of a second diameter larger than said first diameter.
20. The system of claim 18 wherein: the counter-traction member has a longitudinal axis; and, an annular tissue-abutment surface is formed on the proximal end of the frus which is generally perpendicular to the longitudinal axis of the counter-traction member.
21. The system of claim 20 wherein: an annular cutting member is formed on the distal end of the debulker; and, the annular tissue abutment surface comprises a cutting plate which is sized, configured and positioned such that when the debulker is advanced in the first direction, the annular cutting member will register with the cutting plate.
22. A retractable debulking system for enlarging an interstitial tract which extends outwardly from the lumen of an anatomical conduit, said system comprising:
a tubular, proximal counter-force member which has at least one tissueengaging surface formed on the distal end thereof, said proximal counter-force member being advanceable into the lumen of the anatomical conduit from which said interstitial tract extends such that its tissue-engaging surface engages tissue adjacent the interstitial tract; and, a retractable debulker which is advanceable out of the distale end of the proximal counter-force member and through the interstitial tract in a first direction, said debulker being subsequently retractable in a second direction opposite said first direction, said debulker having a at least one tissue removing surface formed on the proximal end thereof to remove tissue located adjacent the interstitial tract as the debulker is retracted in the second direction through the interstitial tract; said proximal counter-traction member being operative to apply a counterforce in the first direction against the tissue adjacent the interstitial tract, as the debulker is being retracted in the second direction to remove said tissue.
23. The system of claim 22 wherein the retractable debulker has aproximal tissue cutting surface, and wherein a tissue-receiving chamber is formed with the debulker adjacent to said tissue cutting surface, such that tissue which has been removed by the debulker will enter said tissue-receiving chamber.
24. The system of claim 22 wherein a guidewire lumen extends through said retractable debulker such that said retractable debulker may be advanced over a guidewire which extends through the interstitial tract.
25. The system of claim 22 further comprising a sheath having a lumen extending longitudinally therethrough, the lumen of said sheath being sized to permit said debulker and said countertraction member to pass therethrough.
26. The system of claim 25 wherein said sheath has a distal end opening out of which said debulker and said countertraction member are passable.
27. The system of claim 25 wherein said sheath has a side opening out of which said debulker and said countertraction member are passable.
28. The system of claim 27 wherein the lumen of the sheath further comprises a deflector surface which is configured and located to deflect said debulker out of said side opening as said debulker is advanced in the distal direction therethrough.
29. The system of claim 22 wherein said retractable debulker comprises an elongate member having a proximal end whereupon an annular cutter is mounted, said annular cutter having a sharpened leading edge so as to sever tissue as it is retracted the proximal direction throught he penetration tract.
30. The system of claim 29 wherein at least the annular cutter of said retractable debulker is rotatable.
31. The system of claim 9 further comprising a motor for rotatably driving at least the annular cutter of said debulker.
32. A laser debulking apparatus, useable for enlarging an interstitial penetration tract, said apparatus comprising:
an elongate flexible member having a guidewire lumen extending longitudinally therethorugh;
a plurality of laser transmitting members extending longitudinally through said flexible member, said laser transmitting members being disposed in a generally annular array,
each of said laser transmitting members having a distal end associated with a laser light transmitting surface whereby laser light from that laser transmitting member will be projected from said flexible member, such that when laser energy is concurrently passed through all of said laser transmitting members, a generally annular patern of laser light will be projected from said apparatus.
33. The apparatus of claim 32 further comprising a suction lumen extending through said flexible member to apply suction to the area into which said pattern of laser light is projected.
34. A laser debulking apparatus, useable for enlarging an interstitial penetration tract, said apparatus comprising:
an elongate flexible member having a guidewire lumen extending longitudinally therethorugh;
a laser transmitting member extending longitudinally through said flexible member;
a prism having at least one light guide groove formed therein, said prism being rotatably positioned on the end of said laser transmitting member such that laser energy which passes through said laser transmitting member will pass into said prism and will be caused by said at least one light guide groove and the concurrent rotation of said prism, to be projected in a generally conical pattern from said apparatus.
35. The apparatus of claim 34 further comprising a suction lumen extending through said flexible member to apply suction to the area into which said pattern of laser light is projected.
36. The apparatus of claim 34 wherein said laser transmitting member is rotatable, and wherein said prism is mounted on the distal end of said laser transmitting member so as to rotate concurrently with said laser transmitting member.
37. A laser debulking apparatus, useable for enlarging an interstitial penetration tract, said apparatus comprising:
an elongate flexible member having a guidewire lumen extending longitudinally therethorugh;
a laser transmitting member extending longitudinally through said flexible member;
a prism having a plurality of light guide grooves formed therein, said light guide grooves being disposed in a generally annular array, said prism being positioned on the end of said laser transmitting member such that laser energy which passes through said laser transmitting member will pass into said prism and will be caused by said plurality light guide grooves to be projected in a generally conical pattern, from said apparatus.
38. The apparatus of claim 37 further comprising a suction lumen extending through said flexible member to apply suction to the area into which said pattern of laser light is projected.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/346,556 US20030181938A1 (en) | 1998-04-07 | 2003-01-17 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/056,589 US6561998B1 (en) | 1998-04-07 | 1998-04-07 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
US10/346,556 US20030181938A1 (en) | 1998-04-07 | 2003-01-17 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/056,589 Continuation US6561998B1 (en) | 1998-04-07 | 1998-04-07 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030181938A1 true US20030181938A1 (en) | 2003-09-25 |
Family
ID=22005419
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/056,589 Expired - Lifetime US6561998B1 (en) | 1998-04-07 | 1998-04-07 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
US10/346,556 Abandoned US20030181938A1 (en) | 1998-04-07 | 2003-01-17 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/056,589 Expired - Lifetime US6561998B1 (en) | 1998-04-07 | 1998-04-07 | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
Country Status (7)
Country | Link |
---|---|
US (2) | US6561998B1 (en) |
EP (1) | EP1069869A4 (en) |
JP (1) | JP2002510522A (en) |
AU (1) | AU763400B2 (en) |
CA (1) | CA2326769A1 (en) |
IL (1) | IL138724A0 (en) |
WO (1) | WO1999051162A1 (en) |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055371A1 (en) * | 1998-01-30 | 2003-03-20 | Percardia, Inc. | Left ventricular conduits to coronary arteries and methods for coronary bypass |
US20030137008A1 (en) * | 2000-03-28 | 2003-07-24 | Hidetoshi Nozaki | Solid state imaging device having a photodiode and a MOSFET and method of manufacturing the same |
US20040133969A1 (en) * | 2003-01-10 | 2004-07-15 | Tyler Pipe Company, A Division Of Ransom Industries, Lp | Closet carrier system and method of assembly |
US20060112956A1 (en) * | 2002-11-06 | 2006-06-01 | Michel Serpelloni | Use of branched malto-dextrins as granulation binders |
US20070118209A1 (en) * | 2000-10-26 | 2007-05-24 | Strecker Ernst P | Implantable valve system |
US20090149766A1 (en) * | 2007-12-11 | 2009-06-11 | Shuros Allan C | Coronary vein hemodynamic sensor |
US20090227836A1 (en) * | 2008-03-06 | 2009-09-10 | Wilson-Cook Medical Inc. | Medical systems for accessing an internal bodily opening |
US20090299427A1 (en) * | 2008-05-27 | 2009-12-03 | Lili Liu | Coronary vein dimensional sensor and fixation apparatus |
US20100049177A1 (en) * | 2008-08-22 | 2010-02-25 | Emed, Inc. | Microdermabrasion System with Combination Skin Therapies |
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US20100305635A1 (en) * | 2009-05-26 | 2010-12-02 | Lili Liu | System and method for rhythm identification and therapy discrimination using hemodynamic status information |
US20100305650A1 (en) * | 2009-06-01 | 2010-12-02 | Barun Maskara | System and method for pacing rate control utilizing patient hemodynamic status information |
US20100305649A1 (en) * | 2009-06-01 | 2010-12-02 | Barun Maskara | System and method for decompensation detection and treatment based on patient hemodynamics |
US20120123457A1 (en) * | 2007-09-24 | 2012-05-17 | Milliman Keith L | Anvil Delivery Device Accessory |
EP2677961A1 (en) * | 2011-02-24 | 2014-01-01 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US9199067B2 (en) | 2009-01-29 | 2015-12-01 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9320530B2 (en) | 2013-03-13 | 2016-04-26 | The Spectranetics Corporation | Assisted cutting balloon |
US9387311B1 (en) | 2014-10-31 | 2016-07-12 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9655626B2 (en) | 2014-04-28 | 2017-05-23 | Covidien Lp | Anvil assembly delivery system |
US9737696B2 (en) | 2014-01-15 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10201387B2 (en) | 2013-03-13 | 2019-02-12 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10272230B2 (en) | 2015-10-30 | 2019-04-30 | Cerevasc, Llc | Systems and methods for treating hydrocephalus |
CN111568507A (en) * | 2020-05-15 | 2020-08-25 | 成都明杰科技有限公司 | Resection device based on polyp in intestinal |
US10842567B2 (en) | 2013-03-13 | 2020-11-24 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10850078B2 (en) | 2014-12-30 | 2020-12-01 | The Spectranetics Corporation | Electrically-induced fluid filled balloon catheter |
US10898213B2 (en) | 2014-12-30 | 2021-01-26 | The Spectranetics Corporation | Electrically-induced pressure wave emitting catheter sheath |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11058492B2 (en) | 2014-12-30 | 2021-07-13 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11246659B2 (en) | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
US11278708B2 (en) | 2014-01-15 | 2022-03-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11684420B2 (en) | 2016-05-05 | 2023-06-27 | Eximo Medical Ltd. | Apparatus and methods for resecting and/or ablating an undesired tissue |
WO2024019717A1 (en) * | 2022-07-20 | 2024-01-25 | Bard Peripheral Vascular, Inc. | Catheters, devices, and methods for endovascular treatment of a blood vessel |
US11951270B2 (en) | 2020-08-05 | 2024-04-09 | Cerevasc, Llc | Systems and methods for endovascularly accessing a subarachnoid space |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8353908B2 (en) * | 1996-09-20 | 2013-01-15 | Novasys Medical, Inc. | Treatment of tissue in sphincters, sinuses, and orifices |
US6723063B1 (en) * | 1998-06-29 | 2004-04-20 | Ekos Corporation | Sheath for use with an ultrasound element |
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
US6231546B1 (en) * | 1998-01-13 | 2001-05-15 | Lumend, Inc. | Methods and apparatus for crossing total occlusions in blood vessels |
US6666874B2 (en) * | 1998-04-10 | 2003-12-23 | Endicor Medical, Inc. | Rotational atherectomy system with serrated cutting tip |
US6406488B1 (en) * | 1998-08-27 | 2002-06-18 | Heartstent Corporation | Healing transmyocardial implant |
JP2002524196A (en) * | 1998-09-10 | 2002-08-06 | パーカーディア,インコーポレイティド | Transmyocardial shunt for left ventricular revascularization and its mounting mechanism |
US6290728B1 (en) * | 1998-09-10 | 2001-09-18 | Percardia, Inc. | Designs for left ventricular conduit |
US6261304B1 (en) | 1998-09-10 | 2001-07-17 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US6253768B1 (en) | 1999-08-04 | 2001-07-03 | Percardia, Inc. | Vascular graft bypass |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
JP4166016B2 (en) * | 2000-01-04 | 2008-10-15 | メドトロニック ヴァスキュラー インコーポレイテッド | A device that forms a pathway between adjacent body lumens |
US6854467B2 (en) * | 2000-05-04 | 2005-02-15 | Percardia, Inc. | Methods and devices for delivering a ventricular stent |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
ES2436668T3 (en) | 2000-12-20 | 2014-01-03 | Covidien Lp | Catheter to remove atheromatous or thrombotic occlusive material |
DE60209799T2 (en) | 2001-12-03 | 2007-01-25 | Ekos Corp., Bothell | CATHETER WITH SEVERAL ULTRASOUND EMITTING PARTS |
WO2003051208A1 (en) * | 2001-12-14 | 2003-06-26 | Ekos Corporation | Blood flow reestablishment determination |
US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
US9440046B2 (en) | 2002-04-04 | 2016-09-13 | Angiodynamics, Inc. | Venous insufficiency treatment method |
ATE504330T1 (en) * | 2002-04-11 | 2011-04-15 | Medtronic Vascular Inc | DEVICES FOR TRANSLUMINAL OR TRANSTHORACAL INTERSTITIAL ELECTRODE PLACEMENT |
US20080208180A1 (en) * | 2002-07-10 | 2008-08-28 | Cartier William A | Endovascular treatment sheath having a heat insulative tip and method for using the same |
WO2004004546A2 (en) * | 2002-07-10 | 2004-01-15 | Angiodynamics, Inc. | Endovascular laser treatment device having a fiber tip spacer |
US20080287939A1 (en) * | 2002-07-10 | 2008-11-20 | Appling William M | Endovascular thermal treatment device with flexible guide tip and method |
WO2008124790A2 (en) | 2002-07-10 | 2008-10-16 | Angiodynamics, Inc. | Device and method for endovascular treatment for causing closure of a blood vessel |
US7326219B2 (en) * | 2002-09-09 | 2008-02-05 | Wilk Patent Development | Device for placing transmyocardial implant |
EP1583569A4 (en) * | 2003-01-03 | 2009-05-06 | Ekos Corp | Ultrasonic catheter with axial energy field |
EP1605987B1 (en) * | 2003-03-13 | 2008-02-20 | Medtronic Vascular, Inc. | Optically guided penetration catheters and their methods of use |
US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
CA2553165A1 (en) * | 2004-01-29 | 2005-08-11 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
US7201737B2 (en) * | 2004-01-29 | 2007-04-10 | Ekos Corporation | Treatment of vascular occlusions using elevated temperatures |
US20050209578A1 (en) * | 2004-01-29 | 2005-09-22 | Christian Evans Edward A | Ultrasonic catheter with segmented fluid delivery |
US20050278013A1 (en) * | 2004-05-26 | 2005-12-15 | Matthew Rust | Method for endovascular bypass stent graft delivery |
GB0419954D0 (en) | 2004-09-08 | 2004-10-13 | Advotek Medical Devices Ltd | System for directing therapy |
US20060111704A1 (en) * | 2004-11-22 | 2006-05-25 | Rox Medical, Inc. | Devices, systems, and methods for energy assisted arterio-venous fistula creation |
US20070032808A1 (en) * | 2005-08-03 | 2007-02-08 | Azam Anwar | System and method for addressing total occlusion in a vascular environment |
US8083727B2 (en) | 2005-09-12 | 2011-12-27 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
EP4292548A3 (en) | 2005-09-12 | 2024-02-28 | Boston Scientific Scimed, Inc. | Endovascular devices |
US8025655B2 (en) | 2005-09-12 | 2011-09-27 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US7918870B2 (en) | 2005-09-12 | 2011-04-05 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US11020141B2 (en) | 2005-09-12 | 2021-06-01 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US20070255303A1 (en) * | 2006-05-01 | 2007-11-01 | Ethicon Endo-Surgery, Inc. | Integrated Guidewire Needle Knife Device |
US20070276419A1 (en) | 2006-05-26 | 2007-11-29 | Fox Hollow Technologies, Inc. | Methods and devices for rotating an active element and an energy emitter on a catheter |
US8192363B2 (en) | 2006-10-27 | 2012-06-05 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US9060802B2 (en) | 2006-11-21 | 2015-06-23 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US11298511B2 (en) | 2006-11-21 | 2022-04-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US10888354B2 (en) | 2006-11-21 | 2021-01-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
US7780691B2 (en) * | 2007-03-21 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Endoscopic tissue resection device |
US9044568B2 (en) | 2007-06-22 | 2015-06-02 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
EP3659664A1 (en) * | 2007-10-22 | 2020-06-03 | Bridgepoint Medical, Inc. | Devices for crossing chronic total occlusions |
US20090118673A1 (en) * | 2007-11-07 | 2009-05-07 | Jerett Creed | Needle injection catheter |
US8337425B2 (en) | 2008-02-05 | 2012-12-25 | Bridgepoint Medical, Inc. | Endovascular device with a tissue piercing distal probe and associated methods |
US8202246B2 (en) | 2008-02-05 | 2012-06-19 | Bridgepoint Medical, Inc. | Crossing occlusions in blood vessels |
US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
US8016842B2 (en) * | 2008-03-25 | 2011-09-13 | Medtronic Vascular, Inc. | Methods for treating vulnerable plaque |
US20090254105A1 (en) * | 2008-04-04 | 2009-10-08 | Medtronic Vascular, Inc. | Anastomotic connectors |
US20090259174A1 (en) * | 2008-04-15 | 2009-10-15 | Medtronic Vascular, Inc. | Methods and devices for treating vulnerable atherosclerotic plaque |
EP2291128B1 (en) | 2008-04-28 | 2016-08-31 | Bridgepoint Medical, Inc. | Apparatus for crossing occlusions in blood vessels |
WO2010039862A1 (en) * | 2008-09-30 | 2010-04-08 | Rox Medical, Inc. | Methods for screening and treating patients with compromised cardiopulmonary function |
KR101645754B1 (en) | 2008-10-13 | 2016-08-04 | 코비디엔 엘피 | Devices and methods for manipulating a catheter shaft |
NL2002597C2 (en) * | 2009-03-06 | 2010-09-07 | Tobrix B V | Endovascular treatment device, system for endovascular treatment and method of operating |
WO2010126882A1 (en) | 2009-04-29 | 2010-11-04 | Fox Hollow Technologies, Inc. | Methods and devices for cutting and abrading tissue |
RU2509538C2 (en) | 2009-05-14 | 2014-03-20 | ТАЙКО ХЕЛСКЕА ГРУП эЛПи | Cleanable atherectomy catheters and methods for using them |
WO2011068932A1 (en) | 2009-12-02 | 2011-06-09 | Fox Hollow Technologies, Inc. | Methods and devices for cutting tissue |
JP5511107B2 (en) | 2009-12-11 | 2014-06-04 | コヴィディエン リミテッド パートナーシップ | Substance removal device and method with improved substance capture efficiency |
KR101493138B1 (en) | 2010-06-14 | 2015-02-12 | 코비디엔 엘피 | Material removal device |
EP2582306B1 (en) | 2010-06-15 | 2023-03-29 | Avenu Medical, Inc. | Systems and methods for creating arteriovenous (av) fistulas |
CA2804525C (en) * | 2010-06-15 | 2018-09-04 | Caymus Medical, Inc. | Intravascular arterial to venous anastomosis and tissue welding catheter |
EP2632352B1 (en) | 2010-10-28 | 2017-04-12 | Covidien LP | Material removal device |
CA2817213C (en) | 2010-11-11 | 2016-06-14 | Covidien Lp | Flexible debulking catheters with imaging and methods of use and manufacture |
US9138230B1 (en) | 2011-04-29 | 2015-09-22 | Avenu Medical, Inc. | Systems and methods for creating arteriovenous (AV) fistulas |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
US8992513B2 (en) | 2011-06-30 | 2015-03-31 | Angiodynamics, Inc | Endovascular plasma treatment device and method of use |
WO2013033426A2 (en) | 2011-09-01 | 2013-03-07 | Covidien Lp | Catheter with helical drive shaft and methods of manufacture |
AU2012324006B2 (en) | 2011-11-04 | 2015-07-16 | Avenu Medical, Inc. | Systems and methods for percutaneous intravascular access and guidewire placement |
US9474562B2 (en) | 2012-02-08 | 2016-10-25 | Avenu Medical, Inc. | Intravascular arterial to venous anastomosis and tissue welding catheter |
US9532844B2 (en) | 2012-09-13 | 2017-01-03 | Covidien Lp | Cleaning device for medical instrument and method of use |
US9943329B2 (en) | 2012-11-08 | 2018-04-17 | Covidien Lp | Tissue-removing catheter with rotatable cutter |
CA2891257C (en) | 2012-11-14 | 2020-07-28 | Avenu Medical, Inc. | Intravascular arterial to venous anastomosis and tissue welding catheter |
US10070866B1 (en) | 2013-08-01 | 2018-09-11 | Avenu Medical, Inc. | Percutaneous arterial to venous anastomosis clip application catheter system and methods |
US10772672B2 (en) | 2014-03-06 | 2020-09-15 | Avenu Medical, Inc. | Systems and methods for percutaneous access and formation of arteriovenous fistulas |
US9545263B2 (en) | 2014-06-19 | 2017-01-17 | Limflow Gmbh | Devices and methods for treating lower extremity vasculature |
WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
WO2016201136A1 (en) | 2015-06-10 | 2016-12-15 | Ekos Corporation | Ultrasound catheter |
US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
JP6531999B2 (en) | 2015-08-21 | 2019-06-19 | アベニュ メディカル インコーポレイテッド | Systems and methods for forming a percutaneous arteriovenous fistula |
US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
JP2019533539A (en) | 2016-11-11 | 2019-11-21 | アベニュ メディカル インコーポレイテッド | System and method for percutaneous endovascular access and wire placement |
CN110730634A (en) | 2017-04-10 | 2020-01-24 | 林弗洛公司 | Apparatus and method for treating the vasculature of a lower limb |
US10470797B1 (en) | 2018-07-17 | 2019-11-12 | SlipStream, LLC | Systems and methods for vascular access |
AU2019359268A1 (en) | 2018-10-09 | 2021-04-08 | Limflow Gmbh | Devices and methods for catheter alignment |
AU2020373046A1 (en) | 2019-11-01 | 2022-05-12 | Limflow Gmbh | Devices and methods for increasing blood perfusion to a distal extremity |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4018228A (en) * | 1975-02-24 | 1977-04-19 | Goosen Carl C | Surgical punch apparatus |
US4926858A (en) * | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US4936668A (en) * | 1988-11-25 | 1990-06-26 | Kei Mori | Light radiator |
US5196308A (en) * | 1985-06-14 | 1993-03-23 | Genetic Systems Corporation | Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus |
US5261904A (en) * | 1990-01-30 | 1993-11-16 | C. R. Bard, Inc. | Laser catheter having diffraction grating for beam shaping |
US5403338A (en) * | 1992-01-21 | 1995-04-04 | Scanlan International, Inc. | Punch for opening passages between two compartments |
US5628762A (en) * | 1994-11-18 | 1997-05-13 | Al-Tameem; Moshin | Method of using a device for excision of a fistula |
US5830222A (en) * | 1995-10-13 | 1998-11-03 | Transvascular, Inc. | Device, system and method for intersititial transvascular intervention |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3974833A (en) | 1973-03-19 | 1976-08-17 | Durden Iii John G | Disposable electrosurgical cautery having optional suction control feature |
DE2324658B2 (en) | 1973-05-16 | 1977-06-30 | Richard Wolf Gmbh, 7134 Knittlingen | PROBE FOR COAGULATING BODY TISSUE |
US4805616A (en) | 1980-12-08 | 1989-02-21 | Pao David S C | Bipolar probes for ophthalmic surgery and methods of performing anterior capsulotomy |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4589412A (en) | 1984-01-03 | 1986-05-20 | Intravascular Surgical Instruments, Inc. | Method and apparatus for surgically removing remote deposits |
US4682596A (en) * | 1984-05-22 | 1987-07-28 | Cordis Corporation | Electrosurgical catheter and method for vascular applications |
US4693556A (en) | 1985-06-04 | 1987-09-15 | Laser Therapeutics, Inc. | Apparatus for producing a spherical pattern of light and method of manufacture |
US4681106A (en) | 1985-08-12 | 1987-07-21 | Intravascular Surgical Instruments, Inc. | Catheter based surgical methods and apparatus therefor |
US4867138A (en) * | 1987-05-13 | 1989-09-19 | Olympus Optical Co., Ltd. | Rigid electronic endoscope |
US4886061A (en) | 1988-02-09 | 1989-12-12 | Medinnovations, Inc. | Expandable pullback atherectomy catheter system |
US4998933A (en) | 1988-06-10 | 1991-03-12 | Advanced Angioplasty Products, Inc. | Thermal angioplasty catheter and method |
EP0347098B1 (en) * | 1988-06-13 | 1996-02-28 | Samuel Shiber | Atherectomy system with a guide-wire |
US5078717A (en) * | 1989-04-13 | 1992-01-07 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
WO1990012545A1 (en) * | 1989-04-18 | 1990-11-01 | Derma-Lase Limited | Method and apparatus for the removal of tattoos |
US5006119A (en) | 1989-05-25 | 1991-04-09 | Engineering & Research Associates, Inc. | Hollow core coaxial catheter |
US4993412A (en) * | 1989-08-02 | 1991-02-19 | Eclipse Surgical Technologies, Inc. | Method and apparatus for removal of obstructive substance from body channels |
US5100425A (en) | 1989-09-14 | 1992-03-31 | Medintec R&D Limited Partnership | Expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses |
US5011490A (en) | 1989-12-07 | 1991-04-30 | Medical Innovative Technologies R&D Limited Partnership | Endoluminal tissue excision catheter system and method |
US5127902A (en) | 1990-09-05 | 1992-07-07 | Medical Innovative Technologies R&D Limited Partnership | Apparatus and method for precisely controlling the excision of obstructive tissue in a human blood vessel |
US5129913A (en) | 1990-10-04 | 1992-07-14 | Norbert Ruppert | Surgical punch apparatus |
US5827315A (en) | 1994-01-04 | 1998-10-27 | Yoon; Inbae | Safety penetrating instrument with penetrating member protected after penetration to predetermined depth |
US5409453A (en) * | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
EP0525176A4 (en) | 1991-02-19 | 1994-07-13 | Fischell Robert | Improved apparatus and method for atherectomy |
FR2675388B1 (en) * | 1991-04-22 | 1993-07-30 | Boussignac Georges | CATHETER FOR INTRODUCTION INTO A BODY CHANNEL. |
DK0609239T3 (en) * | 1991-09-04 | 2000-07-24 | David S Zimmon | Lateral biopsy device |
US5423846A (en) | 1991-10-21 | 1995-06-13 | Cathco, Inc. | Dottering auger catheter system |
US5843019A (en) | 1992-01-07 | 1998-12-01 | Arthrocare Corporation | Shaped electrodes and methods for electrosurgical cutting and ablation |
US5292320A (en) * | 1992-07-06 | 1994-03-08 | Ceramoptec, Inc. | Radial medical laser delivery device |
US5613972A (en) | 1992-07-15 | 1997-03-25 | The University Of Miami | Surgical cutting heads with curled cutting wings |
US5556377A (en) * | 1992-08-12 | 1996-09-17 | Vidamed, Inc. | Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe |
US5522834A (en) | 1992-10-15 | 1996-06-04 | Applied Medical Resources Corporation | Internal mammary artery catheter and method |
DE4307642C1 (en) | 1993-03-11 | 1994-06-09 | Redha Falah | Medical instrument for dispersal of deposits in arteries and/or veins - has partly hollow body with basic body to which cutters are attached having cutting edges pointing in draw direction |
US5514115A (en) | 1993-07-07 | 1996-05-07 | Device For Vascular Intervention, Inc. | Flexible housing for intracorporeal use |
US5527325A (en) | 1993-07-09 | 1996-06-18 | Device For Vascular Intervention, Inc. | Atherectomy catheter and method |
US5396887A (en) * | 1993-09-23 | 1995-03-14 | Cardiac Pathways Corporation | Apparatus and method for detecting contact pressure |
US5599345A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment apparatus |
ES2129803T3 (en) | 1993-12-22 | 1999-06-16 | Sulzer Osypka Gmbh | ULTRASONICALLY MARKED CARDIAC ABLATION CATHETER. |
US5437664A (en) | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
US5672171A (en) | 1994-06-30 | 1997-09-30 | American Medical Systems, Inc. | Apparatus and method for interstitial laser treatment |
US5628761A (en) | 1994-07-08 | 1997-05-13 | Rizik; David G. | Guide wire passage creation device |
US5556397A (en) | 1994-10-26 | 1996-09-17 | Laser Centers Of America | Coaxial electrosurgical instrument |
US5643296A (en) | 1994-12-16 | 1997-07-01 | Devices For Vasclar Intervention | Intravascular catheter with guiding structure |
US5665062A (en) | 1995-01-23 | 1997-09-09 | Houser; Russell A. | Atherectomy catheter and RF cutting method |
US5735844A (en) * | 1995-02-01 | 1998-04-07 | The General Hospital Corporation | Hair removal using optical pulses |
US6106524A (en) | 1995-03-03 | 2000-08-22 | Neothermia Corporation | Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue |
US5620439A (en) | 1995-06-06 | 1997-04-15 | George S. Abela | Catheter and technique for endovascular myocardial revascularization |
US5769816A (en) | 1995-11-07 | 1998-06-23 | Embol-X, Inc. | Cannula with associated filter |
US5755697A (en) | 1995-11-22 | 1998-05-26 | Jones; Calvin E. | Self-tunneling, self-securing percutaneous catheterization device and method of use thereof |
ES2206684T3 (en) * | 1996-02-02 | 2004-05-16 | Transvascular, Inc. | SYSTEM FOR INTERSTICIAL TRANSVASCULAR INTERVENTION. |
AU733465B2 (en) | 1996-03-05 | 2001-05-17 | Tyco Healthcare Group, Lp | Vascular catheter-based system for heating tissue |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
US5725521A (en) | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5738680A (en) * | 1996-04-05 | 1998-04-14 | Eclipse Surgical Technologies, Inc. | Laser device with piercing tip for transmyocardial revascularization procedures |
US5957900A (en) * | 1996-07-10 | 1999-09-28 | Asahi Kogaku Kogyo Kabushiki Kaisha | Treatment accessory for endoscope |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5944716A (en) | 1996-12-09 | 1999-08-31 | Scimed Life Systems, Inc. | Radio frequency transmyocardial revascularization corer |
US5741270A (en) | 1997-02-28 | 1998-04-21 | Lumend, Inc. | Manual actuator for a catheter system for treating a vascular occlusion |
US6026814A (en) | 1997-03-06 | 2000-02-22 | Scimed Life Systems, Inc. | System and method for percutaneous coronary artery bypass |
US6155264A (en) | 1997-03-06 | 2000-12-05 | Scimed Life Systems, Inc. | Percutaneous bypass by tunneling through vessel wall |
US5827324A (en) | 1997-03-06 | 1998-10-27 | Scimed Life Systems, Inc. | Distal protection device |
US6035856A (en) | 1997-03-06 | 2000-03-14 | Scimed Life Systems | Percutaneous bypass with branching vessel |
US5843103A (en) | 1997-03-06 | 1998-12-01 | Scimed Life Systems, Inc. | Shaped wire rotational atherectomy device |
US6047700A (en) * | 1998-03-30 | 2000-04-11 | Arthrocare Corporation | Systems and methods for electrosurgical removal of calcified deposits |
-
1998
- 1998-04-07 US US09/056,589 patent/US6561998B1/en not_active Expired - Lifetime
-
1999
- 1999-04-06 IL IL13872499A patent/IL138724A0/en unknown
- 1999-04-06 WO PCT/US1999/007518 patent/WO1999051162A1/en active IP Right Grant
- 1999-04-06 JP JP2000541938A patent/JP2002510522A/en active Pending
- 1999-04-06 AU AU34737/99A patent/AU763400B2/en not_active Ceased
- 1999-04-06 EP EP99916412A patent/EP1069869A4/en not_active Ceased
- 1999-04-06 CA CA002326769A patent/CA2326769A1/en not_active Abandoned
-
2003
- 2003-01-17 US US10/346,556 patent/US20030181938A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4018228A (en) * | 1975-02-24 | 1977-04-19 | Goosen Carl C | Surgical punch apparatus |
US4926858A (en) * | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US5196308A (en) * | 1985-06-14 | 1993-03-23 | Genetic Systems Corporation | Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus |
US4936668A (en) * | 1988-11-25 | 1990-06-26 | Kei Mori | Light radiator |
US5261904A (en) * | 1990-01-30 | 1993-11-16 | C. R. Bard, Inc. | Laser catheter having diffraction grating for beam shaping |
US5403338A (en) * | 1992-01-21 | 1995-04-04 | Scanlan International, Inc. | Punch for opening passages between two compartments |
US5628762A (en) * | 1994-11-18 | 1997-05-13 | Al-Tameem; Moshin | Method of using a device for excision of a fistula |
US5830222A (en) * | 1995-10-13 | 1998-11-03 | Transvascular, Inc. | Device, system and method for intersititial transvascular intervention |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
Cited By (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055371A1 (en) * | 1998-01-30 | 2003-03-20 | Percardia, Inc. | Left ventricular conduits to coronary arteries and methods for coronary bypass |
US8597226B2 (en) | 1998-09-10 | 2013-12-03 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US8216174B2 (en) | 1998-09-10 | 2012-07-10 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US7736327B2 (en) | 1998-09-10 | 2010-06-15 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US20030137008A1 (en) * | 2000-03-28 | 2003-07-24 | Hidetoshi Nozaki | Solid state imaging device having a photodiode and a MOSFET and method of manufacturing the same |
US20070118209A1 (en) * | 2000-10-26 | 2007-05-24 | Strecker Ernst P | Implantable valve system |
US7776053B2 (en) * | 2000-10-26 | 2010-08-17 | Boston Scientific Scimed, Inc. | Implantable valve system |
US20060112956A1 (en) * | 2002-11-06 | 2006-06-01 | Michel Serpelloni | Use of branched malto-dextrins as granulation binders |
US20040133969A1 (en) * | 2003-01-10 | 2004-07-15 | Tyler Pipe Company, A Division Of Ransom Industries, Lp | Closet carrier system and method of assembly |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US20120123457A1 (en) * | 2007-09-24 | 2012-05-17 | Milliman Keith L | Anvil Delivery Device Accessory |
US8403942B2 (en) * | 2007-09-24 | 2013-03-26 | Covidien Lp | Anvil delivery device accessory |
US20090149766A1 (en) * | 2007-12-11 | 2009-06-11 | Shuros Allan C | Coronary vein hemodynamic sensor |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8974379B2 (en) * | 2008-03-06 | 2015-03-10 | Cook Medical Technologies Llc | Medical systems for accessing an internal bodily opening |
US20090227836A1 (en) * | 2008-03-06 | 2009-09-10 | Wilson-Cook Medical Inc. | Medical systems for accessing an internal bodily opening |
US20090299427A1 (en) * | 2008-05-27 | 2009-12-03 | Lili Liu | Coronary vein dimensional sensor and fixation apparatus |
US8818507B2 (en) | 2008-05-27 | 2014-08-26 | Cardiac Pacemakers, Inc. | Coronary vein dimensional sensor and fixation apparatus |
US8945104B2 (en) * | 2008-08-22 | 2015-02-03 | Envy Medical, Inc. | Microdermabrasion system with combination skin therapies |
US20100049177A1 (en) * | 2008-08-22 | 2010-02-25 | Emed, Inc. | Microdermabrasion System with Combination Skin Therapies |
US10485983B1 (en) | 2008-08-22 | 2019-11-26 | Envy Medical, Inc. | Microdermabrasion system with combination skin therapies |
US9199067B2 (en) | 2009-01-29 | 2015-12-01 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10112036B2 (en) | 2009-01-29 | 2018-10-30 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9737697B2 (en) | 2009-01-29 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US20100305635A1 (en) * | 2009-05-26 | 2010-12-02 | Lili Liu | System and method for rhythm identification and therapy discrimination using hemodynamic status information |
US8417336B2 (en) | 2009-06-01 | 2013-04-09 | Cardiac Pacemakers, Inc. | System and method for pacing rate control utilizing patient hemodynamic status information |
US20100305649A1 (en) * | 2009-06-01 | 2010-12-02 | Barun Maskara | System and method for decompensation detection and treatment based on patient hemodynamics |
US20100305650A1 (en) * | 2009-06-01 | 2010-12-02 | Barun Maskara | System and method for pacing rate control utilizing patient hemodynamic status information |
US8423140B2 (en) | 2009-06-01 | 2013-04-16 | Cardiac Pacemakers, Inc. | System and method for decompensation detection and treatment based on patient hemodynamics |
US8825156B2 (en) | 2009-06-01 | 2014-09-02 | Cardiac Pacemakers, Inc. | System and method for decompensation detection and treatment based on patient hemodynamics |
US8583232B2 (en) * | 2009-06-01 | 2013-11-12 | Cardiac Pacemakers, Inc. | System and method for pacing rate control utilizing patient hemodynamic status information |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
CN107260304A (en) * | 2011-02-24 | 2017-10-20 | 爱克斯莫医疗有限公司 | Hybrid catheter for tissue resection |
US10258409B2 (en) | 2011-02-24 | 2019-04-16 | Eximo Medical Ltd. | Hybrid catheter for endoluminal intervention |
EP2677961A1 (en) * | 2011-02-24 | 2014-01-01 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US10363099B2 (en) | 2011-02-24 | 2019-07-30 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US9763735B2 (en) | 2011-02-24 | 2017-09-19 | Eximo Medical Ltd. | Hybrid catheter for endoluminal intervention |
US11576724B2 (en) | 2011-02-24 | 2023-02-14 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
CN103491892A (en) * | 2011-02-24 | 2014-01-01 | 爱克斯莫医疗有限公司 | Hybrid catheter for vascular intervention |
EP2677961A4 (en) * | 2011-02-24 | 2014-10-29 | Eximo Medical Ltd | Hybrid catheter for vascular intervention |
US9730756B2 (en) | 2011-02-24 | 2017-08-15 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US10786661B2 (en) | 2013-03-13 | 2020-09-29 | The Spectranetics Corporation | Apparatus and method for balloon angioplasty |
US9320530B2 (en) | 2013-03-13 | 2016-04-26 | The Spectranetics Corporation | Assisted cutting balloon |
US10201387B2 (en) | 2013-03-13 | 2019-02-12 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10842567B2 (en) | 2013-03-13 | 2020-11-24 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11278708B2 (en) | 2014-01-15 | 2022-03-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9737696B2 (en) | 2014-01-15 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10596357B2 (en) | 2014-01-15 | 2020-03-24 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9655626B2 (en) | 2014-04-28 | 2017-05-23 | Covidien Lp | Anvil assembly delivery system |
US10524798B2 (en) | 2014-04-28 | 2020-01-07 | Covidien Lp | Anvil assembly delivery system |
US11246659B2 (en) | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
US10279154B2 (en) | 2014-10-31 | 2019-05-07 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9387311B1 (en) | 2014-10-31 | 2016-07-12 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10058686B2 (en) | 2014-10-31 | 2018-08-28 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9662479B2 (en) | 2014-10-31 | 2017-05-30 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10307576B2 (en) | 2014-10-31 | 2019-06-04 | Cerevasc, Llc | Systems and methods for deploying an implant in the vasculature |
US9545505B2 (en) | 2014-10-31 | 2017-01-17 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10765846B2 (en) | 2014-10-31 | 2020-09-08 | CereVasc, Inc. | Methods and systems for draining cerebrospinal fluid into the venous system |
US9724501B2 (en) | 2014-10-31 | 2017-08-08 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9669195B2 (en) | 2014-10-31 | 2017-06-06 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US11058492B2 (en) | 2014-12-30 | 2021-07-13 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US10898213B2 (en) | 2014-12-30 | 2021-01-26 | The Spectranetics Corporation | Electrically-induced pressure wave emitting catheter sheath |
US10850078B2 (en) | 2014-12-30 | 2020-12-01 | The Spectranetics Corporation | Electrically-induced fluid filled balloon catheter |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US10307577B2 (en) | 2015-10-30 | 2019-06-04 | Cerevasc, Llc | Systems and methods for deploying an implant in the vasculature |
US10272230B2 (en) | 2015-10-30 | 2019-04-30 | Cerevasc, Llc | Systems and methods for treating hydrocephalus |
US10758718B2 (en) | 2015-10-30 | 2020-09-01 | CereVasc, Inc. | Systems and methods for endovascularly accessing a subarachnoid space |
US11684420B2 (en) | 2016-05-05 | 2023-06-27 | Eximo Medical Ltd. | Apparatus and methods for resecting and/or ablating an undesired tissue |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11850390B2 (en) | 2018-03-08 | 2023-12-26 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
CN111568507A (en) * | 2020-05-15 | 2020-08-25 | 成都明杰科技有限公司 | Resection device based on polyp in intestinal |
US11951270B2 (en) | 2020-08-05 | 2024-04-09 | Cerevasc, Llc | Systems and methods for endovascularly accessing a subarachnoid space |
WO2024019717A1 (en) * | 2022-07-20 | 2024-01-25 | Bard Peripheral Vascular, Inc. | Catheters, devices, and methods for endovascular treatment of a blood vessel |
Also Published As
Publication number | Publication date |
---|---|
IL138724A0 (en) | 2001-10-31 |
JP2002510522A (en) | 2002-04-09 |
EP1069869A4 (en) | 2006-03-08 |
WO1999051162A1 (en) | 1999-10-14 |
CA2326769A1 (en) | 1999-10-14 |
EP1069869A1 (en) | 2001-01-24 |
US6561998B1 (en) | 2003-05-13 |
AU763400B2 (en) | 2003-07-24 |
AU3473799A (en) | 1999-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6561998B1 (en) | Transluminal devices, systems and methods for enlarging interstitial penetration tracts | |
US11633207B2 (en) | Methods and systems for performing submucosal medical procedures | |
JP6940575B2 (en) | Devices and methods for forming a fistula | |
US5944716A (en) | Radio frequency transmyocardial revascularization corer | |
AU768035B2 (en) | Device for forming holes in tissue | |
US5738680A (en) | Laser device with piercing tip for transmyocardial revascularization procedures | |
US6471700B1 (en) | Apparatus and method for accessing biopsy site | |
US20050187537A1 (en) | Angular deflection apparatus for use in confined spaces and method of use | |
US20100217151A1 (en) | Methods and Systems for Performing Submucosal Medical Procedures | |
EP1253859B1 (en) | Apparatus for creating a channel between adjacent body lumens | |
US7094233B2 (en) | Hollow surgical probe | |
US20160000455A1 (en) | Methods and devices for urethral treatment | |
WO2008084244A2 (en) | Device and method for the treatment of diseased tissue such as tumours | |
JPH0714394B2 (en) | Device and method for supplying laser energy to stromal cells | |
US9107681B2 (en) | Aortic dissection septal cutting tool | |
US20070225702A1 (en) | Apparatus and method of performing radiofrequency cauterization and tissue removal | |
US20160317174A1 (en) | Aortic dissection septal cutting tool | |
CN114302756A (en) | Device for performing interventional endoscopic ultrasound surgery | |
MXPA00009748A (en) | Transluminal devices, systems and methods for enlarging interstitial penetration tracts | |
WO2023069983A1 (en) | Systems and methods for transcatheter surgery | |
Jones et al. | Methods and systems for performing submucosal medical procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC VASCULAR, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRANSVASCULAR, INC.;REEL/FRAME:015000/0001 Effective date: 20030909 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |